10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2024

OR

☐    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from       to      

Commission file number 1-31763

KRONOS WORLDWIDE, INC.

(Exact name of registrant as specified in its charter)

DELAWARE	76-0294959
(State or other jurisdiction of incorporation or organization)	(IRS Employer Identification No.)

5430 LBJ Freeway, Suite 1700

Dallas, Texas 75240-2620

(Address of principal executive offices)

Registrant’s telephone number, including area code: (972) 233-1700

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common stock	KRO	NYSE

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months and (2) has been subject to such filing requirements for the past 90 days.   Yes  ☒    No  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).   Yes  ☒   No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☒
Non-accelerated filer	☐	Smaller reporting company	☐
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).   Yes  ☐    No  ☒

Number of shares of the registrant’s common stock, $.01 par value per share, outstanding on May 1, 2024:  115,027,016.

KRONOS WORLDWIDE, INC. AND SUBSIDIARIES

INDEX

		Page number
Part I.	FINANCIAL INFORMATION
Item 1.	Financial Statements
	Condensed Consolidated Balance Sheets -    December 31, 2023; March 31, 2024 (unaudited)	3
	Condensed Consolidated Statements of Operations (unaudited) -    Three months ended March 31, 2023 and 2024	5
	Condensed Consolidated Statements of Comprehensive Loss (unaudited) -    Three months ended March 31, 2023 and 2024	6
	Condensed Consolidated Statements of Stockholders’ Equity (unaudited) -    Three months ended March 31, 2023 and 2024	7
	Condensed Consolidated Statements of Cash Flows (unaudited) -    Three months ended March 31, 2023 and 2024	8
	Notes to Condensed Consolidated Financial Statements (unaudited)	9
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		18
Item 3.	Quantitative and Qualitative Disclosure About Market Risk		26
Item 4.	Controls and Procedures		27
Part II.	OTHER INFORMATION
Item 1A.	Risk Factors		27
Item 6.	Exhibits	28
Items 2, 3, 4 and 5 of Part II are omitted because there is no information to report.

2

KRONOS WORLDWIDE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In millions)

ASSETS	December 31,		March 31,
	2023		2024
			(unaudited)
Current assets:
Cash and cash equivalents	$	194.7	$	120.7
Restricted cash		2.2		1.6
Accounts and other receivables, net		312.5		348.7
Inventories, net		564.6		475.8
Prepaid expenses and other		43.4		37.9
Total current assets		1,117.4		984.7
Other assets:
Investment in TiO2 manufacturing joint venture		111.0		108.7
Restricted cash		5.2		5.0
Marketable securities		2.2		2.5
Operating lease right-of-use assets		22.7		21.8
Deferred income taxes		83.3		81.8
Other		13.3		13.3
Total other assets		237.7		233.1
Property and equipment:
Land		44.7		43.3
Buildings		236.8		231.1
Equipment		1,172.0		1,143.8
Mining properties		130.5		122.2
Construction in progress		22.9		22.1
		1,606.9		1,562.5
Less accumulated depreciation and amortization		1,124.0		1,100.9
Net property and equipment		482.9		461.6
Total assets	$	1,838.0	$	1,679.4

3

KRONOS WORLDWIDE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS (CONTINUED)

(In millions)

LIABILITIES AND STOCKHOLDERS’ EQUITY	December 31,		March 31,
	2023		2024
			(unaudited)
Current liabilities:
Accounts payable and accrued liabilities	$	355.4	$	251.3
Income taxes		15.4		16.6
Total current liabilities		370.8		267.9
Noncurrent liabilities:
Long-term debt		440.9		426.9
Accrued pension costs		150.0		143.6
Payable to affiliate - income taxes		18.6		18.6
Operating lease liabilities		18.6		17.9
Deferred income taxes		9.0		8.7
Other		21.8		21.4
Total noncurrent liabilities		658.9		637.1
Stockholders’ equity:
Common stock		1.2		1.2
Additional paid-in capital		1,390.2		1,390.2
Retained deficit		(242.0)		(255.8)
Accumulated other comprehensive loss		(341.1)		(361.2)
Total stockholders’ equity		808.3		774.4
Total liabilities and stockholders’ equity	$	1,838.0	$	1,679.4

Commitments and contingencies (Notes 10 and 12)

See accompanying notes to Condensed Consolidated Financial Statements.

4

KRONOS WORLDWIDE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In millions, except per share data)

	Three months ended
	March 31,
	2023		2024
	(unaudited)
Net sales	$	426.3	$	478.8
Cost of sales		395.5		407.3
Gross margin		30.8		71.5
Selling, general and administrative expense		53.2		54.2
Other operating income (expense):
Currency transactions, net		5.4		5.8
Other operating expense, net		(1.3)		(3.6)
Income (loss) from operations		(18.3)		19.5
Other income (expense):
Interest and dividend income		2.0		1.3
Marketable equity securities		(.7)		.3
Other components of net periodic pension and OPEB cost		(.9)		(.3)
Interest expense		(4.2)		(9.2)
Income (loss) before income taxes		(22.1)		11.6
Income tax expense (benefit)		(6.9)		3.5
Net income (loss)	$	(15.2)	$	8.1
Net income (loss) per basic and diluted share	$	(.13)	$	.07
Weighted average shares used in the calculation of      net income (loss) per share		115.3		115.0

See accompanying notes to Condensed Consolidated Financial Statements.

5

KRONOS WORLDWIDE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

(In millions)

	Three months ended
	March 31,
	2023		2024
	(unaudited)
Net income (loss)	$	(15.2)	$	8.1
Other comprehensive income (loss), net of tax:
Currency translation		(7.0)		(20.6)
Defined benefit pension plans		.5		.5
Other postretirement benefit plans		(.1)		-
Total other comprehensive loss, net		(6.6)		(20.1)
Comprehensive loss	$	(21.8)	$	(12.0)

See accompanying notes to Condensed Consolidated Financial Statements.

6

KRONOS WORLDWIDE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(In millions)

	Three months ended March 31, 2023 and 2024 (unaudited)
							Accumulated
			Additional				other
	Common		paid-in		Retained		comprehensive		Treasury
	stock		capital		deficit		loss		stock		Total
Balance at December 31, 2022	$	1.2	$	1,394.3	$	(105.4)	$	(331.5)	$	(1.4)	$	957.2
Net loss		-		-		(15.2)		-		-		(15.2)
Other comprehensive loss, net of tax		-		-		-		(6.6)		-		(6.6)
Dividends paid - $.19 per share		-		-		(21.9)		-		-		(21.9)
Treasury stock acquired		-		-		-		-		(1.4)		(1.4)
Treasury stock retired		-		(1.3)		-		-		1.3		-
Balance at March 31, 2023	$	1.2	$	1,393.0	$	(142.5)	$	(338.1)	$	(1.5)	$	912.1
Balance at December 31, 2023	$	1.2	$	1,390.2	$	(242.0)	$	(341.1)	$	-	$	808.3
Net income		-		-		8.1		-		-		8.1
Other comprehensive loss, net of tax		-		-		-		(20.1)		-		(20.1)
Dividends paid - $.19 per share		-		-		(21.9)		-		-		(21.9)
Balance at March 31, 2024	$	1.2	$	1,390.2	$	(255.8)	$	(361.2)	$	-	$	774.4

See accompanying notes to Condensed Consolidated Financial Statements.

7

KRONOS WORLDWIDE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In millions)

	Three months ended
	March 31,
	2023		2024
	(unaudited)
Cash flows from operating activities:
Net income (loss)	$	(15.2)	$	8.1
Depreciation		12.9		10.9
Amortization of operating lease right-of-use assets		1.1		1.1
Deferred income taxes		1.1		(.2)
Benefit plan expense less than cash funding		(2.2)		(2.8)
Marketable equity securities		.7		(.3)
Distributions from (contributions to) TiO2 manufacturing joint venture, net		(.7)		2.3
Other, net		.4		2.1
Change in assets and liabilities:
Accounts and other receivables, net		(39.0)		(58.3)
Inventories, net		.5		75.6
Prepaid expenses		8.1		4.4
Accounts payable and accrued liabilities		(60.0)		(103.7)
Income taxes		(2.6)		2.0
Accounts with affiliates		(15.1)		15.3
Other, net		.2		.2
Net cash used in operating activities		(109.8)		(43.3)
Cash flows from investing activities - capital expenditures		(16.4)		(4.7)
Cash flows from financing activities:
Loan from Contran		-		53.7
Payments on long-term debt		(.2)		(52.6)
Deferred financing fees		-		(4.9)
Dividends paid		(21.9)		(21.9)
Treasury stock acquired		(1.4)		-
Net cash used in financing activities		(23.5)		(25.7)
Cash, cash equivalents and restricted cash - net change from:
Operating, investing and financing activities		(149.7)		(73.7)
Effect of currency exchange rate changes on cash		(.7)		(1.1)
Balance at beginning of period		334.6		202.1
Balance at end of period	$	184.2	$	127.3
Supplemental disclosures:
Cash paid (received) for:
Interest, net of amount capitalized	$	7.9	$	7.2
Income taxes		(2.6)		.9
Accrual for capital expenditures		6.4		.9

See accompanying notes to Condensed Consolidated Financial Statements.

8

KRONOS WORLDWIDE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2024

(unaudited)

Note 1 - Organization and basis of presentation:

Organization - At March 31, 2024, Valhi, Inc. (NYSE: VHI) held approximately 50% of our outstanding common stock and a wholly-owned subsidiary of NL Industries, Inc. (NYSE: NL) held approximately 31% of our common stock. Valhi owned approximately 83% of NL’s outstanding common stock and a wholly-owned subsidiary of Contran Corporation held approximately 91% of Valhi’s outstanding common stock. A majority of Contran’s outstanding voting stock is held directly by Lisa K. Simmons, Thomas C. Connelly (the husband of Ms. Simmons’ late sister), and various family trusts established for the benefit of Ms. Simmons, Mr. Connelly and their children and for which Ms. Simmons, Mr. Connelly, or Mr. Connelly’s sister, as applicable, serve as trustee (collectively, the “Other Trusts”). With respect to the Other Trusts for which Mr. Connelly or his sister serves as trustee, the trustee is required to vote the shares of Contran voting stock held in such trusts in the same manner as Ms. Simmons. Such voting rights of Ms. Simmons last through April 22, 2030 and are personal to Ms. Simmons. The remainder of Contran’s outstanding voting stock is held by another trust (the “Family Trust”), which was established for the benefit of Ms. Simmons and her late sister and their children and for which a third-party financial institution serves as trustee. Consequently, at March 31, 2024, Ms. Simmons and the Family Trust may be deemed to control Contran, and therefore may be deemed to indirectly control the wholly-owned subsidiary of Contran, Valhi, NL and us.

Basis of presentation - The unaudited Condensed Consolidated Financial Statements contained in this Quarterly Report have been prepared on the same basis as the audited Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2023 that we filed with the Securities and Exchange Commission (SEC) on March 6, 2024 (2023 Annual Report). In our opinion, we have made all necessary adjustments (which include only normal recurring adjustments), in order to state fairly, in all material respects, our consolidated financial position, results of operations and cash flows as of the dates and for the periods presented. We have condensed the Consolidated Balance Sheet at December 31, 2023 contained in this Quarterly Report as compared to our audited Consolidated Financial Statements at that date, and we have omitted certain information and footnote disclosures (including those related to the Consolidated Balance Sheet at December 31, 2023) normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (GAAP). Our results of operations for the interim period ended March 31, 2024 may not be indicative of our operating results for the full year. The Condensed Consolidated Financial Statements contained in this Quarterly Report should be read in conjunction with our 2023 Consolidated Financial Statements contained in our 2023 Annual Report.

Unless otherwise indicated, references in this report to “we,” “us” or “our” refer to Kronos Worldwide, Inc. and its subsidiaries (NYSE: KRO) taken as a whole.

Note 2 - Accounts and other receivables, net:

	December 31,		March 31,
	2023		2024
	(In millions)
Trade receivables	$	273.6	$	330.8
Recoverable VAT and other receivables		23.8		19.5
Receivables from affiliates, other:
Louisiana Pigment Company (LPC)		16.9		-
Other		.4		.4
Refundable income taxes		1.9		2.0
Allowance for doubtful accounts		(4.1)		(4.0)
Total	$	312.5	$	348.7

9

Note 3 - Inventories, net:

	December 31,		March 31,
	2023		2024
	(In millions)
Raw materials	$	188.3	$	148.3
Work in process		30.8		25.6
Finished products		249.6		208.8
Supplies		95.9		93.1
Total	$	564.6	$	475.8

Note 4 - Marketable securities:

Our marketable securities consist of investments in the publicly-traded shares of our related party, Valhi. Our marketable securities are accounted for as available-for-sale securities, which are carried at fair value using quoted market prices in active markets for each marketable security and represent a Level 1 input within the fair value hierarchy. Unrealized gains or losses on equity securities are recognized in Other income (expense) - Marketable equity securities on our Condensed Consolidated Statements of Operations.

	Fair value
	measurement	Market		Cost		Unrealized
Marketable security	level	value		basis		loss
		(In millions)
December 31, 2023:
Valhi common stock	1	$	2.2	$	3.2	$	(1.0)
March 31, 2024:
Valhi common stock	1	$	2.5	$	3.2	$	(.7)

At December 31, 2023 and March 31, 2024, we held approximately 144,000 shares of Valhi’s common stock. At December 31, 2023 and March 31, 2024, the per share quoted market price of Valhi’s common stock was $15.19 and $17.18, respectively.

The Valhi common stock we own is subject to the restrictions on resale pursuant to certain provisions of the Securities and Exchange Commission (SEC) Rule 144. In addition, as a majority-owned subsidiary of Valhi we cannot vote our shares of Valhi common stock under Delaware General Corporation Law, but we do receive dividends from Valhi on these shares when declared and paid.

Note 5 - Long-term debt:

	December 31,		March 31,
	2023		2024
	(In millions)
Kronos International, Inc. 9.50% Senior Secured Notes due 2029	$	-	$	292.3
Kronos International, Inc. 3.75% Senior Secured Notes due 2025		440.9		80.9
Subordinated, Unsecured Term Loan from Contran		-		53.7
Total long-term debt	$	440.9	$	426.9

9.50% Senior Secured Notes due 2029 - On February 12, 2024, for certain eligible holders of existing 3.75% Senior Secured Notes due 2025 (the “Old Notes”) of our wholly-owned subsidiary, Kronos International, Inc. (KII), KII executed an exchange of €325 million principal amount of the outstanding Old Notes for newly issued €276.174 million aggregate outstanding KII 9.50% Senior Secured Notes due March 2029 (the “New Notes” and together with the Old Notes, the “Senior Secured Notes”) plus additional cash consideration of €48.75 million ($52.6 million). Holders of the Old Notes received for each €1,000 principal amount of Old Notes exchanged, €850 in principal amount of New Notes, plus a cash payment in an amount equal to €150. Following the exchange, Old Notes totaling €75 million principal amount that were not exchanged continue to remain outstanding. In connection with the exchange, the indenture governing the Old Notes was amended to conform to the restrictive covenants in the indenture governing the New Notes

10

and to make other conforming changes. KII did not receive any cash proceeds from the issuance and delivery of the New Notes in connection with the exchange. We also entered into a new $53.7 million unsecured term loan from Contran Corporation (described below) in connection with the exchange.

The New Notes:

● bear interest at 9.50% per annum, payable semi-annually on March 15 and September 15 of each year, payments begin on September 15, 2024;

● have a maturity date of March 15, 2029. Prior to March 15, 2026, we may redeem some or all of the New Notes at a price equal to 100% of the principal amount thereof, plus an applicable premium as of the date of the redemption as described in the indenture governing our New Notes plus accrued and unpaid interest. On or after March 15, 2026, we may redeem the New Notes at redemption prices ranging from 104.750% of the principal amount, declining to 100% on or after March 15, 2028, plus accrued and unpaid interest. In addition, on or before March 15, 2026, we may redeem up to 40% of the New Notes with the net proceeds of certain public or private equity offerings at 109.50% of the principal amount, plus accrued and unpaid interest, provided that following the redemption at least 50% of the New Notes remain outstanding. If we or our subsidiaries experience certain change of control events, as outlined in the indenture governing our New Notes, we would be required to make an offer to purchase the New Notes at 101% of the principal amount thereof, plus accrued and unpaid interest. We would also be required to make an offer to purchase a specified portion of the New Notes at par value, plus accrued and unpaid interest, in the event that we and our subsidiaries generate a certain amount of net proceeds from the sale of assets outside the ordinary course of business, and such net proceeds are not otherwise used for specified purposes within a specified time period as described in the indenture governing our New Notes;

● are fully and unconditionally guaranteed, jointly and severally, on a senior secured basis by Kronos Worldwide, Inc. and each of our direct and indirect domestic, wholly-owned subsidiaries;

● are collateralized by a first priority lien on (i) 100% of the common stock or other ownership interests of each existing and future direct domestic subsidiary of KII and the guarantors, and (ii) 65% of the voting common stock or other ownership interests and 100% of the non-voting common stock or other ownership interests of each non-U.S. subsidiary that is directly owned by KII or any guarantor;

● contain a number of covenants and restrictions which, among other things, restrict our ability to incur or guarantee additional debt, incur liens, pay dividends or make other restricted payments, or merge or consolidate with, or sell or transfer substantially all of our assets to, another entity, and contain other provisions and restrictive covenants customary in lending transactions of this type (however, there are no ongoing financial maintenance covenants); and

● contain customary default provisions, including a default under any of our other indebtedness in excess of $50.0 million.

At March 31, 2024 the carrying value of the New Notes (€276.174 million aggregate principal amount outstanding) is stated net of unamortized debt issuance costs of $5.6 million. As a result of the note exchange, in the first quarter of 2024 we recognized a non-cash pre-tax interest charge of $1.5 million included in interest expense related to the write-off of the deferred financing costs associated with the Old Notes and capitalized $5.7 million in debt issuance costs associated with the New Notes.    

Subordinated, Unsecured Term Loan from Contran - As part of the refinancing of a majority of our Old Notes discussed above, we borrowed $53.7 million (€50.0 million) from Contran through the issuance of an unsecured, subordinated term promissory note dated February 12, 2024 (the “Contran Term Loan”). The Contran Term Loan is guaranteed by our domestic wholly-owned subsidiaries. Our obligations under the Contran Term Loan, and the obligations of the guarantors under the related guaranties, are unsecured and subordinated in right of payment to our Senior Secured Notes and our $225 million global revolving credit facility (Global Revolver). Interest on the Contran Term Loan is payable in cash at an interest rate of 11.5%. The additional interest rate spread of 2% over the interest rate on the New Notes was based upon comparable debt transactions at the time of issuance. The Contran Term Loan matures on demand (but no earlier than September 2029), is not subject to any amortization payments and is prepayable at par beginning in March 2026. The restrictive covenants in the Contran Term Loan are substantially similar to those contained in the indenture governing our New Notes. In accordance with our related party transaction policy, the audit committee of our board of directors, comprised of the independent directors, approved the terms and conditions of the term loan from Contran.

11

3.75% Senior Secured Notes due 2025 - At March 31, 2024, the carrying value of our remaining Old Notes (€75 million aggregate principal amount outstanding) is $80.9 million. In connection with the issuance of the New Notes in February 2024, the indenture governing the Old Notes was amended to conform to the restrictive covenants in the indenture governing the New Notes and to make other conforming changes.

Revolving credit facility - During the first three months of 2024, we had no borrowings or repayments under our $225 million global revolving credit facility and at March 31, 2024, the full $225 million was available for borrowing.

Other - We are in compliance with all of our debt covenants at March 31, 2024.

Note 6 - Accounts payable and accrued liabilities:

	December 31,		March 31,
	2023		2024
	(In millions)
Accounts payable	$	218.7	$	143.9
Accrued sales discounts and rebates		22.5		10.5
Employee benefits		24.7		23.4
Payables to affiliates:
LPC		19.9		21.0
Income taxes payable to Valhi		10.8		11.6
Other		.6		.6
Operating lease liabilities		3.9		3.6
Other		54.3		36.7
Total	$	355.4	$	251.3

Note 7 - Other noncurrent liabilities:

	December 31,		March 31,
	2023		2024
	(In millions)
Accrued postretirement benefits	$	6.4	$	6.2
Employee benefits		4.9		4.7
Other		10.5		10.5
Total	$	21.8	$	21.4

12

Note 8 - Revenue recognition:

The following table disaggregates our net sales by place of manufacture (point of origin) and to the location of the customer (point of destination), which are the categories that depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors.

	Three months ended
	March 31,
	2023		2024
	(In millions)
Net sales - point of origin:
United States	$	255.8	$	240.9
Germany		186.0		212.2
Canada		90.9		89.3
Norway		71.9		71.0
Belgium		68.8		69.6
Eliminations		(247.1)		(204.2)
Total	$	426.3	$	478.8
Net sales - point of destination:
Europe	$	201.1	$	214.9
North America		148.6		166.0
Other		76.6		97.9
Total	$	426.3	$	478.8

Note 9 - Employee benefit plans:

The components of net periodic defined benefit pension cost are presented in the table below.

	Three months ended
	March 31,
	2023		2024
	(In millions)
Net periodic pension cost (income):
Service cost	$	1.6	$	1.7
Interest cost		5.1		5.0
Expected return on plan assets		(4.8)		(5.3)
Recognized actuarial losses		.6		.6
Total	$	2.5	$	2.0

We expect our 2024 contributions for our pension plans to be approximately $17 million.

13

Note 10 - Income taxes:

	Three months ended
	March 31,
	2023		2024
	(In millions)
Expected tax expense (benefit), at U.S. federal statutory     income tax rate of 21%	$	(4.6)	$	2.4
Non-U.S. tax rates		(.2)		-
Incremental net tax benefit on earnings and losses of U.S.    and non-U.S. companies		-		(.6)
Valuation allowance, net		.2		1.0
Global intangible low-tax income, net		(.5)		.3
Adjustment to the reserve for uncertain tax positions, net		(1.2)		.1
Adjustment of prior year taxes, net		(.4)		-
Nondeductible expenses		-		.2
Other, net		(.2)		.1
Income tax expense (benefit)	$	(6.9)	$	3.5
Comprehensive provision (benefit) for income taxes allocable to:
Net income (loss)	$	(6.9)	$	3.5
Other comprehensive income - pension plans		.1		.2
Total	$	(6.8)	$	3.7

The amount shown in the preceding table of our income tax rate reconciliation for non-U.S. tax rates represents the result determined by multiplying the pre-tax earnings or losses of each of our non-U.S. subsidiaries by the difference between the applicable statutory income tax rate for each non-U.S. jurisdiction and the U.S. federal statutory tax rate. The amount shown on such table for incremental net tax benefit on earnings and losses of U.S. and non-U.S. companies includes, as applicable, (i) deferred income taxes (or deferred income tax benefits) associated with the current-year earnings (losses) of all of our non-U.S. subsidiaries and (ii) current U.S. income taxes (or current income tax benefit), including U.S. personal holding company tax, as applicable, attributable to current-year income (losses) of one of our non-U.S. subsidiaries, which subsidiary is treated as a dual resident for U.S. income tax purposes, to the extent the current-year income (losses) of such subsidiary is subject to U.S. income tax under the U.S. dual-resident provisions of the Internal Revenue Code.

During the first quarter of 2023, we recognized a non-cash deferred income tax benefit of $1.0 million relating to a decrease in our unrecognized tax benefits due to the expiration of certain statutes of limitations.

Tax authorities are examining certain of our U.S. and non-U.S. tax returns and may propose tax deficiencies, including penalties and interest. We believe we have adequate accruals for additional taxes and related interest expense which could ultimately result from tax examinations. We believe the ultimate disposition of tax examinations should not have a material adverse effect on our consolidated financial position, results of operations or liquidity. We currently estimate that our unrecognized tax benefits will not change materially during the next twelve months.

14

Note 11 - Stockholders’ equity:

Changes in accumulated other comprehensive loss are presented in the table below. See Note 9 for discussion of our defined benefit pension plans.

	Three months ended
	March 31,
	2023		2024
	(In millions)
Accumulated other comprehensive loss, net of tax:
Currency translation:
Balance at beginning of period	$	(269.2)	$	(265.5)
Other comprehensive loss		(7.0)		(20.6)
Balance at end of period	$	(276.2)	$	(286.1)
Defined benefit pension plans:
Balance at beginning of period	$	(63.1)	$	(76.0)
Other comprehensive income - amortization    of prior service cost and net losses included in    net periodic pension cost		.5		.5
Balance at end of period	$	(62.6)	$	(75.5)
OPEB plans:
Balance at beginning of period	$	.8	$	.4
Other comprehensive loss - amortization    of prior service credit and net losses    included in net periodic OPEB cost		(.1)		-
Balance at end of period	$	.7	$	.4
Total accumulated other comprehensive loss:
Balance at beginning of period	$	(331.5)	$	(341.1)
Other comprehensive loss		(6.6)		(20.1)
Balance at end of period	$	(338.1)	$	(361.2)

Our board of directors has previously authorized the repurchase of up to 2.0 million shares of our common stock in open market transactions, including block purchases, or in privately-negotiated transactions at unspecified prices and over an unspecified period of time. We may repurchase our common stock from time to time as market conditions permit. The stock repurchase program does not include specific price targets or timetables and may be suspended at any time. Depending on market conditions, we may terminate the program prior to its completion. We use cash on hand or other sources of liquidity to acquire the shares. Repurchased shares are added to our treasury and subsequently cancelled upon approval of the board of directors.

In February 2023, we cancelled 133,897 shares of treasury stock purchased in the fourth quarter of 2022. During the first quarter of 2023, we acquired 159,796 shares of our common stock in market transactions for an aggregate purchase price of $1.4 million, which shares were accounted for as treasury stock at March 31, 2023 and were subsequently cancelled. At March 31, 2024, 1,017,518 shares are available for repurchase under this stock repurchase program.

15

Note 12 - Commitments and contingencies:

We are involved in various environmental, contractual, product liability, patent (or intellectual property), employment and other claims and disputes incidental to our business. At least quarterly our management discusses and evaluates the status of any pending litigation to which we are a party. The factors considered in such evaluation include, among other things, the nature of such pending cases, the status of such pending cases, the advice of legal counsel and our experience in similar cases (if any). Based on such evaluation, we make a determination as to whether we believe (i) it is probable a loss has been incurred, and if so if the amount of such loss (or a range of loss) is reasonably estimable, or (ii) it is reasonably possible but not probable a loss has been incurred, and if so if the amount of such loss (or a range of loss) is reasonably estimable, or (iii) the probability a loss has been incurred is remote. We have not accrued any amounts for litigation matters because it is not reasonably possible we have incurred a loss that would be material to our consolidated financial statements, results of operations or liquidity.

Note 13 - Financial instruments:

See Note 4 for information on how we determine fair value of our marketable securities.

The following table presents the financial instruments that are not carried at fair value but which require fair value disclosure:

	December 31, 2023				March 31, 2024
	Carrying		Fair		Carrying		Fair
	amount		value		amount		value
	(In millions)
Cash, cash equivalents and restricted cash	$	202.1	$	202.1	$	127.3	$	127.3
Long-term debt:
Fixed rate 9.50% Senior Secured Notes due 2029		-		-		292.3		318.5
Fixed rate 3.75% Senior Secured Notes due 2025		440.9		424.5		80.9		79.9

At March 31, 2024, the estimated market price of our 9.50% Senior Secured Notes due 2029 was €1,069 per €1,000 principal amount, and the estimated market price of our 3.75% Senior Secured Notes due 2025 was €987 per €1,000 principal amount. The fair values of our Senior Secured Notes were based on quoted market prices; however, these quoted market prices represented Level 2 inputs because the markets in which the Senior Secured Notes trade were not active. Due to their near-term maturities, the carrying amounts of accounts receivable and accounts payable are considered equivalent to fair value. See Notes 2 and 6.

Note 14 - Other operating income (expense), net:

On August 24, 2020, LPC temporarily halted production due to Hurricane Laura. Although storm damage to core processing facilities was not extensive, a variety of factors, including loss of utilities and limited access and availability of employees and raw materials, prevented the resumption of operations until September 25, 2020. The majority of our losses from property damage and our share of LPC’s lost production and other costs resulting from the disruption of operations, were covered by insurance. We recognized an aggregate gain of $1.7 million in the first quarter of 2023, which is included in other operating expense, net on our Condensed Consolidated Statement of Operations.

Note 15 - Recent accounting pronouncements:

In November 2023, the Financial Accounting Standards Board (FASB) issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The ASU requires public companies to disclose significant segment expenses and other segment items on an annual and interim basis. The ASU also mandates public companies to provide all annual segment disclosures currently required annually in interim periods. Public entities with a single reportable segment are required to provide the new disclosures and all disclosures required under ASC 280. Public companies will also be required to disclose the title and position of the chief operating decision maker (CODM) and explain how the CODM uses the reported measure of segment profit or loss in assessing segment performance and allocation of resources. The ASU is effective for us beginning with our 2024 Annual Report, and for interim reporting, in the first quarter of 2025, with retrospective application required. We are in the process of evaluating the additional disclosure requirements across all segments.

16

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The ASU requires additional annual disclosure and disaggregation for the rate reconciliation, income taxes paid and income tax expense by federal, state and foreign tax jurisdictions. In addition, the standard increases the disclosure requirements for items included in the rate reconciliation that meet a quantitative threshold. The ASU is effective for us beginning with our 2025 Annual Report. The ASU may be applied prospectively; however, entities have the option to apply it retrospectively. We are in the process of evaluating the additional disclosure requirements.

Note 16 – Restructuring costs:

In response to the extended period of reduced demand in 2023, we took measures to reduce our operating costs and improve our long-term cost structure such as the implementation of certain voluntary and involuntary workforce reductions during the third quarter of 2023 that primarily impacted our European operations. A substantial portion of our workforce reductions were accomplished through voluntary programs, for which eligible workforce reduction costs are recognized at the time both the employee and employer are irrevocably committed to the terms of the separation. These workforce reductions impacted approximately 100 employees. We recognized a total of approximately $6 million in charges primarily in the fourth quarter of 2023 related to workforce reductions we implemented during the second half of the year with the majority of related cash payments expected to be paid in the first half of 2024.

In April 2024, we announced plans to close our sulfate process line at our plant in Varennes, Canada by the third quarter of 2024. As a result of the sulfate process line closure, we expect to recognize a charge of approximately $2 million primarily to cost of sales in the second quarter of 2024 related to workforce reductions for employees impacted. In addition, approximately $15 million in non-cash charges related to the closure of the line are expected to be reflected in cost of sales in the second and third quarters of 2024.

A summary of the activity in our accrued restructuring costs for the first quarter of 2024 is shown in the table below (in millions):

	Amount
	(In millions)
Accrued workforce reduction costs at December 31, 2023	$	5.0
Workforce reduction costs accrued		(.1)
Workforce reduction costs paid		(1.6)
Currency translation adjustments, net		(.1)
Accrued workforce reduction costs at March 31, 2024	$	3.2
Amounts recognized in the balance sheet:
Current liability	$	3.2
Noncurrent liability		-
Total	$	3.2

17

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

RESULTS OF OPERATIONS

Business overview

We are a leading global producer and marketer of value-added titanium dioxide pigments (TiO₂). TiO₂ is used for a variety of manufacturing applications, including paints, plastics, paper and other industrial and specialty products. For the three months ended March 31, 2024, approximately 40% of our sales volumes were sold into European markets. Our production facilities are located in Europe and North America.

We consider TiO₂ to be a “quality of life” product, with demand affected by gross domestic product, or GDP, and overall economic conditions in our markets located in various regions of the world. Over the long-term, we expect demand for TiO₂ will grow by 2% to 3% per year, consistent with our expectations for the long-term growth in GDP. However, even if we and our competitors maintain consistent shares of the worldwide market, demand for TiO₂ in any interim or annual period may not change in the same proportion as the change in GDP, in part due to relative changes in the TiO₂ inventory levels of our customers. We believe our customers’ inventory levels are influenced in part by their expectation for future changes in TiO₂ selling prices as well as their expectation for future availability of product. Although certain of our TiO₂ grades are considered specialty pigments, the majority of our grades and substantially all of our production are considered commodity pigment products with price and availability being the most significant competitive factors along with product quality and customer and technical support services.

The factors having the most impact on our reported operating results are:

● TiO₂ selling prices,

● TiO₂ sales and production volumes,

● Manufacturing costs, particularly raw materials such as third-party feedstock, maintenance and energy-related expenses, and

● Currency exchange rates (particularly the exchange rate for the U.S. dollar relative to the euro, the Norwegian krone and the Canadian dollar and the euro relative to the Norwegian krone).

Our key performance indicators are our TiO₂ average selling prices, our level of TiO₂ sales and production volumes and the cost of titanium-containing feedstock purchased from third parties. TiO₂ selling prices generally follow industry trends and selling prices will increase or decrease generally as a result of competitive market pressures.

Executive summary

We reported net income of $8.1 million, or $.07 per share, in the first quarter of 2024 compared to a net loss of $15.2 million, or $.13 per share, in the first quarter of 2023. Net income increased in the first quarter of 2024 as compared to the first quarter of 2023 primarily due to higher income from operations as a result of the net effects of higher sales and production volumes, lower average TiO₂ selling prices and lower productions costs (primarily energy and raw materials). Our results of operations for the first quarter of 2023 were significantly impacted by reduced demand for certain of our products occurring in all major markets and unabsorbed fixed production and other costs due to reduced production volumes. Demand has improved in all of our major markets in the first quarter of 2024 and production volumes have increased, contributing to our improved profitability. Comparability of our results was also impacted by the effects of changes in currency exchange rates.

Our net income in the first three months of 2024 includes an aggregate charge of $1.5 million ($1.1 million, or $.01 per share, net of income tax benefit) related to a write-off of deferred financing costs.

Our net loss in the first three months of 2023 includes the recognition of a pre-tax insurance settlement gain of $1.7 million ($1.3 million, or $.01 per share, net of income tax expense) related to a business interruption insurance claim arising from Hurricane Laura in 2020.

18

Forward-looking information

This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Statements in this Quarterly Report on Form 10-Q that are not historical facts are forward-looking in nature and represent management’s beliefs and assumptions based on currently available information. In some cases you can identify forward-looking statements by the use of words such as “believes,” “intends,” “may,” “should,” “could,” “anticipates,” “expects” or comparable terminology, or by discussions of strategies or trends. Although we believe the expectations reflected in such forward-looking statements are reasonable, we do not know if these expectations will be correct. Such statements by their nature involve substantial risks and uncertainties that could significantly impact expected results. Actual future results could differ materially from those predicted. The factors that could cause our actual future results to differ materially from those described herein are the risks and uncertainties discussed in this Quarterly Report and those described from time to time in our other filings with the SEC and include, but are not limited to, the following:

● Future supply and demand for our products

● The extent of the dependence of certain of our businesses on certain market sectors

● The cyclicality of our business

● Customer and producer inventory levels

● Unexpected or earlier-than-expected industry capacity expansion

● Changes in raw material and other operating costs (such as energy and ore costs)

● Changes in the availability of raw materials (such as ore)

● General global economic and political conditions that harm the worldwide economy, disrupt our supply chain, increase material and energy costs or reduce demand or perceived demand for our TiO₂ products or impair our ability to operate our facilities (including changes in the level of gross domestic product in various regions of the world, natural disasters, terrorist acts, global conflicts and public health crises)

● Operating interruptions (including, but not limited to, labor disputes, leaks, natural disasters, fires, explosions, unscheduled or unplanned downtime, transportation interruptions, certain regional and world events or economic conditions and public health crises)

● Technology related disruptions (including, but not limited to, cyber attacks; software implementation, upgrades or improvements; technology processing failures; or other events) related to our technology infrastructure that could impact our ability to continue operations, or at key vendors which could impact our supply chain, or at key customers which could impact their operations and cause them to curtail or pause orders

● Competitive products and substitute products

● Customer and competitor strategies

● Potential consolidation of our competitors

● Potential consolidation of our customers

● The impact of pricing and production decisions

● Competitive technology positions

● Potential difficulties in upgrading or implementing accounting and manufacturing software systems

● The introduction of trade barriers or trade disputes

● Fluctuations in currency exchange rates (such as changes in the exchange rate between the U.S. dollar and each of the euro, the Norwegian krone and the Canadian dollar and between the euro and the Norwegian krone), or possible disruptions to our business resulting from uncertainties associated with the euro or other currencies

● Our ability to renew or refinance credit facilities

19

● Increases in interest rates

● Our ability to maintain sufficient liquidity

● The ultimate outcome of income tax audits, tax settlement initiatives or other tax matters, including future tax reform

● Our ability to utilize income tax attributes, the benefits of which may or may not have been recognized under the more-likely-than-not recognition criteria

● Environmental matters (such as those requiring compliance with emission and discharge standards for existing and new facilities)

● Government laws and regulations and possible changes therein including new environmental, health, safety, sustainability or other regulations (such as those seeking to limit or classify TiO₂ or its use)

● Pending or possible future litigation or other actions.

Should one or more of these risks materialize (or the consequences of such a development worsen), or should the underlying assumptions prove incorrect, actual results could differ materially from those forecasted or expected. We disclaim any intention or obligation to update or revise any forward-looking statements whether as a result of changes in information, future events or otherwise.

Results of operations

Current industry conditions

We and the TiO₂ industry experienced an extended period of significantly reduced demand across all major markets which was reflected in our sales volumes in the first quarter of and throughout 2023. Although overall demand remains below average historical levels, demand has improved in the first quarter of 2024 in all major markets. We started 2024 with average TiO₂ selling prices 13% lower than at the beginning of 2023 and our average TiO₂ selling prices declined 2% during the first quarter of 2024. Our average TiO₂ selling prices in the first three months of 2024 were 11% lower than average prices during the first three months of 2023.

We operated our production facilities at 76% of practical capacity utilization in the first three months of 2023 in response to decreased demand and higher production costs. As a result of increased demand experienced in the fourth quarter of 2023 and first quarter of 2024, along with more favorable production costs, we began increasing our production rates during the first quarter of 2024 resulting in 87% of practical capacity utilization in the first three months of 2024.

Excluding the effect of changes in currency exchange rates, our cost of sales per metric ton of TiO₂ sold in the first three months of 2024 was significantly lower as compared to the comparable period in 2023 primarily due to significant decreases in per metric ton production costs (primarily feedstock and unabsorbed fixed costs due to reduced operating rates in 2023).

In response to the extended period of reduced demand in 2023, discussed above, we took measures to reduce our operating costs and improve our long-term cost structure such as the implementation of certain voluntary and involuntary workforce reductions during the third quarter of 2023 that primarily impacted our European operations. A substantial portion of our workforce reductions were accomplished through voluntary programs, for which eligible workforce reduction costs are recognized at the time both the employee and employer are irrevocably committed to the terms of the separation. These workforce reductions impacted approximately 100 employees. We recognized a total of approximately $6 million in charges primarily in the fourth quarter of 2023 related to workforce reductions we implemented during the second half of the year with the majority of related cash payments expected to be paid in the first half of 2024.

In April 2024, we announced plans to close our sulfate process line at our plant in Varennes, Canada by the third quarter of 2024. We expect to recognize a charge of approximately $2 million primarily to cost of sales in the second quarter of 2024 related to workforce reductions for employees impacted. In addition, approximately $15 million in non-cash charges related to the closure of the line are expected to be reflected in cost of sales in the second and third quarters of 2024.

20

Quarter ended March 31, 2024 compared to the quarter ended March 31, 2023

		Three months ended March 31,
		2023			2024
		(Dollars in millions)
Net sales	$	426.3	100	%	$	478.8	100	%
Cost of sales		395.5	93			407.3	85
Gross margin		30.8	7			71.5	15
Selling, general and administrative expense		53.2	12			54.2	11
Other operating income (expense):
Currency transactions, net		5.4	1			5.8	1
Other operating expense, net		(1.3)	-			(3.6)	(1)
Income (loss) from operations	$	(18.3)	(4)	%	$	19.5	4	%
							% Change
TiO2 operating statistics:
Sales volumes*		102				130	28	%
Production volumes*		105				121	15	%
Percentage change in net sales:
TiO2 sales volumes							28	%
TiO2 product pricing							(11)
TiO2 product mix/other							(6)
Changes in currency exchange rates							1
Total							12	%

* Thousands of metric tons

Net sales - Net sales in the first quarter of 2024 increased 12%, or $52.5 million, compared to the first quarter of 2023 primarily due to the net effects of a 28% increase in sales volumes (which increased net sales by approximately $119 million) and an 11% decrease in average TiO₂ selling prices (which decreased net sales by approximately $47 million). In addition to the impact of sales volumes and average TiO₂ selling prices, we estimate that changes in currency exchange rates (primarily the euro) increased our net sales by approximately $4 million in the first quarter of 2024 as compared to the first quarter of 2023. TiO₂ selling prices will increase or decrease generally as a result of competitive market pressures, changes in the relative level of supply and demand as well as changes in raw material and other manufacturing costs.

Our sales volumes increased 28% in the first quarter of 2024 as compared to the first quarter of 2023 due to higher overall demand across all major markets.  

Cost of sales and gross margin - Cost of sales increased $11.8 million, or 3%, in the first quarter of 2024 compared to the first quarter of 2023 due to the net effects of a 28% increase in sales volumes, a 15% increase in production volumes (in response to improved near-term customer demand) somewhat offset by lower production costs of approximately $64 million (primarily energy and raw materials). Our unabsorbed fixed production costs decreased $10 million from $22 million in the first quarter of 2023 to $12 million in the first quarter of 2024.

Our cost of sales as a percentage of net sales improved to 85% in the first quarter of 2024 compared to 93% in the same period of 2023 primarily due to the favorable effects of lower production costs and higher production volumes resulting in increased coverage of fixed production costs.  

Gross margin as a percentage of net sales increased to 15% in the first quarter of 2024 compared to 7% in the first quarter of 2023. As discussed and quantified above, our gross margin as a percentage of net sales increased primarily due to lower production costs and higher production and sales volumes, somewhat offset by lower average TiO₂ selling prices.

21

Selling, general and administrative expense - Selling, general and administrative expense increased $1.0 million, or 2%, in 2024 compared to 2023 primarily due to variable costs related to higher sales volumes during the quarter. Selling, general and administrative expense as a percentage of net sales decreased to 11% in the first quarter of 2024 compared to 12% of net sales in the first quarter of 2023.

Income (loss) from operations - Income from operations increased by $37.8 million to $19.5 million in the first quarter of 2024 compared to a net loss from operations of $18.3 million in the first quarter of 2023 as a result of the factors impacting gross margin discussed above. We recognized a gain of $1.7 million in the first quarter of 2023 related to cash received from the settlement of a business interruption insurance claim. See Note 14 to our Condensed Consolidated Financial Statements. Changes in currency exchange rates had a nominal effect on our income from operations in the first quarter of 2024 as compared to the same period in 2023, as discussed in the Effects of currency exchange rates section below.

Other non-operating income (expense) - We recognized an unrealized gain of $.3 million in the first quarter of 2024 compared to an unrealized loss of $.7 million in the first quarter of 2023 related to the change in market price of our marketable equity securities. See Note 4 to our Condensed Consolidated Financial Statements. Other components of net periodic pension and OPEB cost in the first quarter of 2024 decreased $.6 million compared to the first quarter of 2023 primarily due to a higher expected return on plan assets. Interest expense in the first quarter of 2024 increased $5.0 million compared to interest expense in the first quarter of 2023 as a result of the February 2024 exchange of €325 million of our 3.75% Senior Secured Notes due 2025 for newly issued €276.174 million of 9.50% Senior Secured Notes due March 2029 plus additional cash consideration, and as a result of the new $53.7 million subordinated, unsecured term loan from Contran due September 2029 at an interest rate of 11.5%, which we entered into in February 2024 in connection with the exchange. As a result of the exchange, interest expense for the first three months of 2024 includes a charge of $1.5 million for the write-off of deferred financing costs. See Note 5 to our Condensed Consolidated Financial Statements.

Income tax expense (benefit) - We recognized income tax expense of $3.5 million in the first quarter of 2024 compared to an income tax benefit of $6.9 million in the first quarter of 2023. The difference is primarily due to higher earnings in the first quarter of 2024 and the jurisdictional mix of such earnings. Our earnings and losses are subject to income tax in various U.S. and non-U.S. jurisdictions, and the income tax rates applicable to the pre-tax earnings (losses) of our non-U.S. operations are generally higher than the income tax rates applicable to our U.S. operations. We would generally expect our overall effective tax rate, excluding the effect of any increase or decrease in our deferred income tax asset valuation allowance or changes in our reserve for uncertain tax positions, to be higher than the U.S. federal statutory tax rate of 21% primarily because of our sizeable non-U.S. operations. However, in the first quarter of 2024, our consolidated effective income tax rate, excluding the effect of the valuation allowance and change in reserve for uncertain tax positions, is lower than the U.S. federal statutory rate of 21% due to the effect of lower earnings and tax benefits associated with losses incurred in certain high tax jurisdictions. See Note 10 to our Condensed Consolidated Financial Statements.

The Organization for Economic Cooperation and Development (the “OECD”), the European Union and other countries have committed to enacting the OECD’s Pillar Two initiative that would provide a global minimum level of taxation for multinational companies to be applied on a country-by-country basis. Currently, many countries are drafting or have enacted legislation to implement the Pillar Two rules effective for years beginning on or after December 31, 2023. Based on legislation currently enacted, we do not anticipate any material impact to our Consolidated Financial Statements; however, until all the jurisdictions we operate in enact legislation, the full impact of Pillar Two to us is unknown.

Effects of currency exchange rates

We have substantial operations and assets located outside the United States (primarily in Germany, Belgium, Norway and Canada). The majority of our sales from non-U.S. operations are denominated in currencies other than the U.S. dollar, principally the euro, other major European currencies and the Canadian dollar. A portion of our sales generated from our non-U.S. operations is denominated in the U.S. dollar (and consequently our non-U.S. operations will generally hold U.S. dollars from time to time). Certain raw materials used in all our production facilities, primarily titanium-containing feedstocks, are purchased primarily in U.S. dollars, while labor and other production and administrative costs are incurred primarily in local currencies. Consequently, the translated U.S. dollar value of our non-U.S. sales and operating results are subject to currency exchange rate fluctuations which may favorably or unfavorably impact reported earnings and may affect the comparability of period-to-period operating results. In addition to the impact of the translation of sales and expenses over time, our non-U.S. operations also generate currency transaction gains and losses which primarily relate to (i) the difference between the currency exchange rates in effect when non-local currency sales or operating costs (primarily U.S. dollar denominated) are initially accrued and when such amounts are settled with the non-local currency, and (ii) changes in currency exchange rates during time periods when our non-U.S. operations are holding non-local currency (primarily U.S. dollars).

22

Overall, we estimate that fluctuations in currency exchange rates had the following effects on our sales and income (loss) from operations for the periods indicated.

Impact of changes in currency exchange rates
Three months ended March 31, 2024 vs March 31, 2023
							Translation		Total
							gains -		currency
	Transaction gains recognized						impact of		impact
	2023		2024		Change		rate changes		2024 vs 2023
		(In millions)
Impact on:
Net sales	$	-	$	-	$	-	$	4	$	4
Income from operations		5		5		-		-		-

The $4 million increase in net sales (translation gains) was caused primarily by a weakening of the U.S. dollar relative to the euro, as our euro-denominated sales were translated into more U.S. dollars in 2024 as compared to 2023. The strengthening of the U.S. dollar relative to the Norwegian krone in 2024 and the weakening of the U.S. dollar relative to the Canadian dollar in 2024 did not have a significant effect on our net sales, as a substantial portion of the sales generated by our Canadian and Norwegian operations is denominated in the U.S. dollar.

The impact of currency exchange rates on our income from operations was nominal.

Outlook

During the first quarter of 2024 we experienced improved customer demand across all major markets, although overall demand levels remain below historical averages. Based on the recently experienced improved demand and our expectation that demand will continue to improve in 2024, along with the severe demand contraction we experienced during most of 2023, we expect sales volumes in 2024 to exceed 2023 sales volumes. We have increased production rates in line with the current and expected near-term improved demand and believe our production rates for the remainder of 2024 will continue to be higher than comparable periods in 2023. We have implemented TiO₂ selling price increases which will need to be realized to achieve margins more in-line with historical levels.  

As noted above, throughout 2023 we implemented cost reduction initiatives designed to improve our long-term cost structure, including targeted workforce reductions and, in April 2024, we announced plans to close the sulfate process line at our facility in Canada which will further improve our gross margins after the charges (primarily non-cash) related to the closure are recognized in the second and third quarters. In addition, raw material, energy and other input costs have generally improved compared to 2023. The full positive impact of input cost improvements and our cost reduction efforts are not yet fully reflected in our gross margin. As we replace the higher cost inventory produced towards the end of 2023 with lower cost inventory produced in 2024, coupled with the realization of TiO₂ selling price increases noted above, we expect gross margins to improve. Overall, due to expected improved demand, higher selling prices and lower production costs, including lower unabsorbed fixed costs, we expect to report higher operating results for the full year of 2024 as compared to 2023.

We believe the production curtailments and other necessary actions we took during 2023 to preserve liquidity while maintaining our global market share have positioned us to capitalize on the increase in demand in 2024 and we expect liquidity levels to improve as the recovery continues. However, we are closely monitoring current and anticipated near-term customer demand levels and will align our production and inventories accordingly.

Our expectations for the TiO₂ industry and our operations are based on a number of factors outside our control. We have experienced global market disruptions including high energy costs and future impacts on our operations will depend on, among other things, future energy costs and the impact economic conditions and geopolitical events have on our operations or our customers’ and suppliers’ operations, all of which remain uncertain and cannot be predicted.

23

LIQUIDITY AND CAPITAL RESOURCES

Consolidated cash flows

Operating activities

Trends in cash flows as a result of our operating activities (excluding the impact of significant asset dispositions and relative changes in assets and liabilities) are generally similar to trends in our earnings. In addition to the impact of the operating, investing and financing cash flows discussed below, changes in the amount of cash, cash equivalents and restricted cash we report from period to period can be impacted by changes in currency exchange rates, since a portion of our cash, cash equivalents and restricted cash is held by our non-U.S. subsidiaries.

Cash used in operating activities was $43.3 million in the first three months of 2024 compared to cash used of $109.8 million in the first three months of 2023. This $66.5 million decrease in the amount of cash used was primarily due to the net effect of the following:

● higher income from operations in 2024 of $37.8 million,

● lower amount of net cash used associated with relative changes in our inventories, receivables, payables and accruals in 2024 of $32.0 million,

● higher cash paid for taxes in 2024 of $3.5 million due to the relative timing of payments, and

● higher net distributions from our TiO₂ manufacturing joint venture in 2024 of $3.0 million.

Changes in working capital were affected by accounts receivable and inventory changes. As shown below:

● Our average days sales outstanding, or DSO, decreased slightly from December 31, 2023 to March 31, 2024 primarily due to relative changes in the timing of collections, and

● Our average days sales in inventory, or DSI, decreased from December 31, 2023 to March 31, 2024 primarily due to lower inventory volumes attributable to sales volumes exceeding production volumes in the first quarter of 2024 compared to the fourth quarter of 2023 where our production volumes aligned more closely with sales volumes.

For comparative purposes, we have also provided comparable prior year numbers below.

	December 31, 2022	March 31, 2023	December 31, 2023	March 31, 2024
DSO	64 days	60 days	66 days	65 days
DSI	103 days	76 days	65 days	46 days

Investing activities

Our capital expenditures of $4.7 million and $16.4 million in the first three months of 2024 and 2023, respectively, were primarily to maintain and improve the cost effectiveness of our manufacturing facilities.

Financing activities

During each of the first quarters of 2023 and 2024, we paid quarterly dividends of $.19 per share to stockholders aggregating $21.9 million.

In addition, during the first three months of 2024, in connection with the exchange of €325 million of our existing Kronos International, Inc. (KII) 3.75% Senior Secured Notes due September 2025 (the “Old Notes”) for our newly issued €276.174 million KII 9.50% Senior Secured Notes due March 2029 (the “New Notes”) plus additional cash consideration, we paid cash consideration of $52.6 million to certain eligible holders of the Old Notes and borrowed $53.7 million from Contran. See Note 5 to our Condensed Consolidated Financial Statements.

24

Outstanding debt obligations

At March 31, 2024, our consolidated debt comprised:

● €276.174 million aggregate outstanding on our New Notes ($292.3 million carrying amount, net of unamortized debt issuance costs),

● €75 million aggregate outstanding on our Old Notes (and together with the New Notes, the “Senior Secured Notes”) ($80.9 million carrying amount), and

● $53.7 million outstanding on our subordinated, unsecured term loan from Contran due September 2029 (the “Contran Term Loan”).

We had no outstanding borrowings at March 31, 2024 on our $225 million global revolving credit facility (Global Revolver). Availability under the Global Revolver is subject to a borrowing base calculation, as defined in the agreement, and at March 31, 2024, the full $225 million was available for borrowings. Our Senior Secured Notes, the Contran Term Loan and our Global Revolver contain a number of covenants and restrictions which, among other things, restrict our ability to incur or guarantee additional debt, incur liens, pay dividends or make other restricted payments, or merge or consolidate with, or sell or transfer substantially all of our assets to, another entity, and contain other provisions and restrictive covenants customary in lending transactions of these types. Our credit agreements contain provisions which could result in the acceleration of indebtedness prior to their stated maturity for reasons other than defaults for failure to comply with typical financial or payment covenants. For example, the credit agreements allow the lender to accelerate the maturity of the indebtedness upon a change of control (as defined in the agreement) of the borrower. In addition, the credit agreements could result in the acceleration of all or a portion of the indebtedness following a sale of assets outside the ordinary course of business. The terms of all of our debt instruments are discussed in Note 8 to our Consolidated Financial Statements included in our 2023 Annual Report. We are in compliance with all of our debt covenants at March 31, 2024. We believe we will be able to continue to comply with the financial covenants contained in our credit facility through its maturity.

Our assets consist primarily of investments in operating subsidiaries, and our ability to service our obligations, including the Senior Secured Notes and the Contran Term Loan, depends in part upon the distribution of earnings of our subsidiaries, whether in the form of dividends, advances or payments on account of intercompany obligations or otherwise. Our Senior Secured Notes are collateralized by, among other things, a first priority lien on (i) 100% of the common stock or other ownership interests of each existing and future direct domestic subsidiary of KII and the guarantors, and (ii) 65% of the voting common stock or other ownership interests and 100% of the non-voting common stock or other ownership interests of each non-U.S. subsidiary that is directly owned by KII or any guarantor. Our Global Revolver is collateralized by, among other things, a first priority lien on the borrower’s trade receivables and inventories. See Note 5 to our Condensed Consolidated Financial Statements.

Future cash requirements

Liquidity

Our primary source of liquidity on an ongoing basis is cash flows from operating activities which is generally used to (i) fund capital expenditures, (ii) repay any short-term indebtedness incurred for working capital purposes, (iii) provide for the payment of dividends and (iv) fund purchases of shares of our common stock under our stock repurchase program. From time-to-time we will incur indebtedness, generally to (i) fund short-term working capital needs, (ii) refinance existing indebtedness or (iii) fund major capital expenditures or the acquisition of other assets outside the ordinary course of business. We will also from time-to-time sell assets outside the ordinary course of business and use the proceeds to (i) repay existing indebtedness, (ii) make investments in marketable and other securities, (iii) fund major capital expenditures or the acquisition of other assets outside the ordinary course of business or (iv) pay dividends.

The TiO₂ industry is cyclical, and changes in industry economic conditions significantly impact earnings and operating cash flows. Changes in TiO₂ pricing, production volumes and customer demand, among other things, could significantly affect our liquidity.

We routinely evaluate our liquidity requirements, alternative uses of capital, capital needs and availability of resources in view of, among other things, our dividend policy, our debt service, our capital expenditure requirements and estimated future operating cash flows. As a result of this process, we have in the past and may in the future seek to reduce, refinance, repurchase or restructure

25

indebtedness, raise additional capital, repurchase shares of our common stock, modify our dividend policy, restructure ownership interests, sell interests in our subsidiaries or other assets, or take a combination of these steps or other steps to manage our liquidity and capital resources. Such activities have in the past and may in the future involve related companies. We may also from time to time engage in preliminary discussions with existing or potential investors regarding the timing or terms of any such refinancing or other potential transaction. In the normal course of our business, we may investigate, evaluate, discuss and engage in acquisition, joint venture, strategic relationship and other business combination opportunities in the TiO₂ industry. In the event of any future acquisition or joint venture opportunity, we may consider using then-available liquidity, issuing our equity securities or incurring additional indebtedness.

At March 31, 2024 we had aggregate cash, cash equivalents and restricted cash on hand of $127.3 million, of which $69.9 million was held by non-U.S. subsidiaries. Following implementation of a territorial tax system under the 2017 Tax Act, repatriation of any cash and cash equivalents held by our non-U.S. subsidiaries would not be expected to result in any material income tax liability as a result of such repatriation. Our $225 million Global Revolver we entered into in April 2021 matures in April 2026 and at March 31, 2024 the full $225 million is available for borrowing under this facility. The borrowing base is calculated quarterly and the amount available for borrowing may change based on applicable quarter end balances. See Note 5 to our Condensed Consolidated Financial Statements. Based upon our expectation for the TiO₂ industry and anticipated demands on cash resources, we expect to have sufficient liquidity to meet our short-term obligations (defined as the twelve-month period ending March 31, 2025) and our long-term obligations (defined as the five-year period ending March 31, 2029, our time period for long-term budgeting). If actual developments differ from our expectations, our liquidity could be adversely affected.

Capital expenditures

We intend to invest approximately $50 million in capital expenditures primarily to maintain and improve our existing facilities during 2024, including $4.7 million in expenditures through March 31, 2024. It is possible we will delay planned capital projects based on market conditions including but not limited to expected demand, the general availability of materials, equipment and supplies necessary to complete such projects.

Stock repurchase program

At March 31, 2024, we have 1,017,518 shares available for repurchase under a stock repurchase program authorized by our board of directors.

Commitments and contingencies

See Notes 10 and 12 to our Condensed Consolidated Financial Statements for a description of certain income tax contingencies, certain legal proceedings and other commitments.

Recent accounting pronouncements

See Note 15 to our Condensed Consolidated Financial Statements.

Critical accounting policies

For a discussion of our critical accounting policies, refer to Part I, Item 7 - “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our 2023 Annual Report. There have been no changes in our critical accounting policies during the first three months of 2024.

ITEM 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK

General

We are exposed to market risk, including currency exchange rates, interest rates, equity security and raw material prices. There have been no material changes in these market risks since we filed our 2023 Annual Report. See also Part I, Item 7A. - “Quantitative and Qualitative Disclosure About Market Risk” in our 2023 Annual Report and Note 13 to our Condensed Consolidated Financial Statements.

26

ITEM 4.    CONTROLS AND PROCEDURES

Evaluation of disclosure controls and procedures

We maintain disclosure controls and procedures which, as defined in Exchange Act Rule 13a-15(e), means controls and other procedures that are designed to ensure that information required to be disclosed in the reports that we file or submit to the SEC under the Securities Exchange Act of 1934, as amended (the “Act”), is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information we are required to disclose in the reports we file or submit to the SEC under the Act is accumulated and communicated to our management, including our principal executive officer and our principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions to be made regarding required disclosure. Each of James M. Buch, our President and Chief Executive Officer and Tim C. Hafer, our Executive Vice President and Chief Financial Officer, has evaluated the design and effectiveness of our disclosure controls and procedures as of March 31, 2024. Based upon their evaluation, these executive officers have concluded that our disclosure controls and procedures are effective as of the date of such evaluation.

Internal control over financial reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting which, as defined by Exchange Act Rule 13a-15(f) means a process designed by, or under the supervision of, our principal executive and principal financial officers, or persons performing similar functions, and effected by the board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles, and includes those policies and procedures that:

● Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of our assets,

● Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors, and

● Provide reasonable assurance regarding prevention or timely detection of an unauthorized acquisition, use or disposition of our assets that could have a material effect on our Condensed Consolidated Financial Statements.

Other

As permitted by the SEC, our assessment of internal control over financial reporting excludes (i) internal control over financial reporting of our equity method investees and (ii) internal control over the preparation of any financial statement schedules which would be required by Article 12 of Regulation S-X. However, our assessment of internal control over financial reporting with respect to our equity method investees did include our controls over the recording of amounts related to our investment that are recorded in our Condensed Consolidated Financial Statements, including controls over the selection of accounting methods for our investments, the recognition of equity method earnings and losses and the determination, valuation and recording of our investment account balances.

Changes in internal control over financial reporting

There has been no change to our internal control over financial reporting during the quarter ended March 31, 2024 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Part II. OTHER INFORMATION

Item 1A.   Risk Factors

For a discussion of the risk factors related to our businesses, refer to Part I, Item 1A, “Risk Factors,” in our 2023 Annual Report.

27

Item 6.Exhibits

31.1	Certification
31.2	Certification
32.1	Certification
101.INS	Inline XBRL Instance - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH	Inline XBRL Taxonomy Extension Schema
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase
104	Cover page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

28

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	Kronos Worldwide, Inc.
	(Registrant)
Date: May 8, 2024	/s/ Tim C. Hafer
	Tim C. Hafer
	Executive Vice President and Chief Financial Officer (duly authorized officer)

29

EX-31.1

Exhibit 31.1

CERTIFICATION

I, James M. Buch, certify that:

1) I have reviewed this quarterly report on Form 10-Q of Kronos Worldwide, Inc.;

2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3) Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4) The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5) The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 8, 2024

/s/ James M. Buch

James M. Buch

Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION

I, Tim C. Hafer, certify that:

1) I have reviewed this quarterly report on Form 10-Q of Kronos Worldwide, Inc.;

2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3) Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4) The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5) The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 8, 2024

/s/ Tim C. Hafer

Tim C. Hafer

Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Kronos Worldwide, Inc. (the Company) on Form 10-Q for the quarter ended March 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, James M. Buch, Chief Executive Officer of the Company, and I, Tim C. Hafer, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ James M. Buch

James M. Buch

Chief Executive Officer

/s/ Tim C. Hafer

Tim C. Hafer

Chief Financial Officer

May 8, 2024

Note: The certification the registrant furnishes in this exhibit is not deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. Registration Statements or other documents filed with the Securities and Exchange Commission shall not incorporate this exhibit by reference, except as otherwise expressly stated in such filing.

XML

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2024	May 01, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2024
Document Transition Report	false
Entity File Number	1-31763
Entity Registrant Name	KRONOS WORLDWIDE, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	76-0294959
Entity Address, Address Line One	5430 LBJ Freeway
Entity Address, Address Line Two	Suite 1700
Entity Address, City or Town	Dallas
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	75240-2620
City Area Code	972
Local Phone Number	233-1700
Title of 12(b) Security	Common stock
Trading Symbol	KRO
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		115,027,016
Entity Central Index Key	0001257640
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Amendment Flag	false

XML

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 120.7	$ 194.7
Restricted cash	1.6	2.2
Accounts and other receivables, net	348.7	312.5
Inventories, net	475.8	564.6
Prepaid expenses and other	37.9	43.4
Total current assets	984.7	1,117.4
Other assets:
Investment in TiO2 manufacturing joint venture	108.7	111.0
Restricted cash	5.0	5.2
Marketable securities	2.5	2.2
Operating lease right-of-use assets	21.8	22.7
Deferred income taxes	81.8	83.3
Other	13.3	13.3
Total other assets	233.1	237.7
Property and equipment:
Land	43.3	44.7
Buildings	231.1	236.8
Equipment	1,143.8	1,172.0
Mining properties	122.2	130.5
Construction in progress	22.1	22.9
Gross property and equipment	1,562.5	1,606.9
Less accumulated depreciation and amortization	1,100.9	1,124.0
Net property and equipment	461.6	482.9
Total assets	1,679.4	1,838.0
Current liabilities:
Accounts payable and accrued liabilities	251.3	355.4
Income taxes	16.6	15.4
Total current liabilities	267.9	370.8
Noncurrent liabilities:
Long-term debt	426.9	440.9
Accrued pension costs	143.6	150.0
Operating lease liabilities	17.9	18.6
Deferred income taxes	8.7	9.0
Other	21.4	21.8
Total noncurrent liabilities	637.1	658.9
Stockholders' equity:
Common stock	1.2	1.2
Additional paid-in capital	1,390.2	1,390.2
Retained deficit	(255.8)	(242.0)
Accumulated other comprehensive loss	(361.2)	(341.1)
Total stockholders' equity	774.4	808.3
Total liabilities and stockholders' equity	1,679.4	1,838.0
Related party
Noncurrent liabilities:
Payable to affiliate - income taxes	$ 18.6	$ 18.6

XML

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
CONSOLIDATED STATEMENTS OF OPERATIONS
Net sales	$ 478.8	$ 426.3
Cost of sales	407.3	395.5
Gross margin	71.5	30.8
Selling, general and administrative expense	54.2	53.2
Other operating income (expense):
Currency transactions, net	5.8	5.4
Other operating expense, net	(3.6)	(1.3)
Income (loss) from operations	19.5	(18.3)
Other income (expense):
Interest and dividend income	1.3	2.0
Marketable equity securities	0.3	(0.7)
Other components of net periodic pension and OPEB cost	(0.3)	(0.9)
Interest expense	(9.2)	(4.2)
Income (loss) before income taxes	11.6	(22.1)
Income tax expense (benefit)	3.5	(6.9)
Net income (loss)	$ 8.1	$ (15.2)
Net income (loss) per share - basic	$ 0.07	$ (0.13)
Net income (loss) per share - diluted	$ 0.07	$ (0.13)
Weighted average shares outstanding - basic	115.0	115.3
Weighted average shares outstanding - diluted	115.0	115.3

XML

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Net income (loss)	$ 8.1	$ (15.2)
Other comprehensive income (loss), net of tax:
Currency translation	(20.6)	(7.0)
Total other comprehensive loss, net	(20.1)	(6.6)
Comprehensive loss	(12.0)	(21.8)
Defined benefit pension plans
Other comprehensive income (loss), net of tax:
Defined benefit pension plans	$ 0.5	0.5
Other postretirement benefit plans
Other comprehensive income (loss), net of tax:
Defined benefit pension plans		$ (0.1)

XML

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Millions	Common stock	Additional paid-in capital	Retained deficit	Accumulated other comprehensive loss	Treasury Stock	Total
Beginning Balance at Dec. 31, 2022	$ 1.2	$ 1,394.3	$ (105.4)	$ (331.5)	$ (1.4)	$ 957.2
Net loss			(15.2)			(15.2)
Other comprehensive loss, net of tax				(6.6)		(6.6)
Dividends paid			(21.9)			(21.9)
Treasury stock acquired					(1.4)	(1.4)
Treasury stock retired		(1.3)			1.3
Ending Balance at Mar. 31, 2023	1.2	1,393.0	(142.5)	(338.1)	$ (1.5)	912.1
Beginning Balance at Dec. 31, 2023	1.2	1,390.2	(242.0)	(341.1)		808.3
Net loss			8.1			8.1
Other comprehensive loss, net of tax				(20.1)		(20.1)
Dividends paid			(21.9)			(21.9)
Ending Balance at Mar. 31, 2024	$ 1.2	$ 1,390.2	$ (255.8)	$ (361.2)		$ 774.4

XML

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) - $ / shares	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
Cash dividends per share	$ 0.19	$ 0.19

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities:
Net income (loss)	$ 8.1	$ (15.2)
Depreciation	10.9	12.9
Amortization of operating lease right-of-use assets	1.1	1.1
Deferred income taxes	(0.2)	1.1
Benefit plan expense less than cash funding	(2.8)	(2.2)
Marketable equity securities	(0.3)	0.7
Distributions from (contributions to) TiO2 manufacturing joint venture, net	2.3	(0.7)
Other, net	2.1	0.4
Change in assets and liabilities:
Accounts and other receivables, net	(58.3)	(39.0)
Inventories, net	75.6	0.5
Prepaid expenses	4.4	8.1
Accounts payable and accrued liabilities	(103.7)	(60.0)
Income taxes	2.0	(2.6)
Accounts with affiliates	15.3	(15.1)
Other, net	0.2	0.2
Net cash used in operating activities	(43.3)	(109.8)
Cash flows from investing activities:
Capital expenditures	(4.7)	(16.4)
Cash flows from financing activities:
Loan from Contran	53.7
Payments on long-term debt	(52.6)	(0.2)
Deferred financing fees	(4.9)
Dividends paid	(21.9)	(21.9)
Treasury stock acquired		(1.4)
Net cash used in financing activities	(25.7)	(23.5)
Cash, cash equivalents and restricted cash - net change from:
Operating, investing and financing activities	(73.7)	(149.7)
Effect of currency exchange rate changes on cash	(1.1)	(0.7)
Balance at beginning of period	202.1	334.6
Balance at end of period	127.3	184.2
Cash paid (received) for:
Interest, net of amount capitalized	7.2	7.9
Income taxes	0.9	(2.6)
Accrual for capital expenditures	$ 0.9	$ 6.4

XML

Organization and basis of presentation

3 Months Ended

Mar. 31, 2024

Organization and basis of presentation

Organization and basis of presentation

Note 1 - Organization and basis of presentation:

Organization - At March 31, 2024, Valhi, Inc. (NYSE: VHI) held approximately 50% of our outstanding common stock and a wholly-owned subsidiary of NL Industries, Inc. (NYSE: NL) held approximately 31% of our common stock. Valhi owned approximately 83% of NL’s outstanding common stock and a wholly-owned subsidiary of Contran Corporation held approximately 91% of Valhi’s outstanding common stock. A majority of Contran’s outstanding voting stock is held directly by Lisa K. Simmons, Thomas C. Connelly (the husband of Ms. Simmons’ late sister), and various family trusts established for the benefit of Ms. Simmons, Mr. Connelly and their children and for which Ms. Simmons, Mr. Connelly, or Mr. Connelly’s sister, as applicable, serve as trustee (collectively, the “Other Trusts”). With respect to the Other Trusts for which Mr. Connelly or his sister serves as trustee, the trustee is required to vote the shares of Contran voting stock held in such trusts in the same manner as Ms. Simmons. Such voting rights of Ms. Simmons last through April 22, 2030 and are personal to Ms. Simmons. The remainder of Contran’s outstanding voting stock is held by another trust (the “Family Trust”), which was established for the benefit of Ms. Simmons and her late sister and their children and for which a third-party financial institution serves as trustee. Consequently, at March 31, 2024, Ms. Simmons and the Family Trust may be deemed to control Contran, and therefore may be deemed to indirectly control the wholly-owned subsidiary of Contran, Valhi, NL and us.

Basis of presentation - The unaudited Condensed Consolidated Financial Statements contained in this Quarterly Report have been prepared on the same basis as the audited Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2023 that we filed with the Securities and Exchange Commission (SEC) on March 6, 2024 (2023 Annual Report). In our opinion, we have made all necessary adjustments (which include only normal recurring adjustments), in order to state fairly, in all material respects, our consolidated financial position, results of operations and cash flows as of the dates and for the periods presented. We have condensed the Consolidated Balance Sheet at December 31, 2023 contained in this Quarterly Report as compared to our audited Consolidated Financial Statements at that date, and we have omitted certain information and footnote disclosures (including those related to the Consolidated Balance Sheet at December 31, 2023) normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (GAAP). Our results of operations for the interim period ended March 31, 2024 may not be indicative of our operating results for the full year. The Condensed Consolidated Financial Statements contained in this Quarterly Report should be read in conjunction with our 2023 Consolidated Financial Statements contained in our 2023 Annual Report.

Unless otherwise indicated, references in this report to “we,” “us” or “our” refer to Kronos Worldwide, Inc. and its subsidiaries (NYSE: KRO) taken as a whole.

XML

Accounts and other receivables, net

3 Months Ended

Mar. 31, 2024

Accounts and other receivables, net

Accounts and other receivables, net

Note 2 - Accounts and other receivables, net:

	December 31,		March 31,
	2023		2024
	(In millions)
Trade receivables	$	273.6	$	330.8
Recoverable VAT and other receivables		23.8		19.5
Receivables from affiliates, other:
Louisiana Pigment Company (LPC)		16.9		-
Other		.4		.4
Refundable income taxes		1.9		2.0
Allowance for doubtful accounts		(4.1)		(4.0)
Total	$	312.5	$	348.7

XML

Inventories, net

3 Months Ended

Mar. 31, 2024

Inventories, net

Inventories, net

Note 3 - Inventories, net:

	December 31,		March 31,
	2023		2024
	(In millions)
Raw materials	$	188.3	$	148.3
Work in process		30.8		25.6
Finished products		249.6		208.8
Supplies		95.9		93.1
Total	$	564.6	$	475.8

XML

Marketable securities

3 Months Ended

Mar. 31, 2024

Marketable securities

Marketable securities

Note 4 - Marketable securities:

Our marketable securities consist of investments in the publicly-traded shares of our related party, Valhi. Our marketable securities are accounted for as available-for-sale securities, which are carried at fair value using quoted market prices in active markets for each marketable security and represent a Level 1 input within the fair value hierarchy. Unrealized gains or losses on equity securities are recognized in Other income (expense) - Marketable equity securities on our Condensed Consolidated Statements of Operations.

	Fair value
	measurement	Market		Cost		Unrealized
Marketable security	level	value		basis		loss
		(In millions)
December 31, 2023:
Valhi common stock	1	$	2.2	$	3.2	$	(1.0)
March 31, 2024:
Valhi common stock	1	$	2.5	$	3.2	$	(.7)

At December 31, 2023 and March 31, 2024, we held approximately 144,000 shares of Valhi’s common stock. At December 31, 2023 and March 31, 2024, the per share quoted market price of Valhi’s common stock was $15.19 and $17.18, respectively.

The Valhi common stock we own is subject to the restrictions on resale pursuant to certain provisions of the Securities and Exchange Commission (SEC) Rule 144. In addition, as a majority-owned subsidiary of Valhi we cannot vote our shares of Valhi common stock under Delaware General Corporation Law, but we do receive dividends from Valhi on these shares when declared and paid.

XML

Long-term debt

3 Months Ended

Mar. 31, 2024

Long-term debt

Long-term debt

Note 5 - Long-term debt:

	December 31,		March 31,
	2023		2024
	(In millions)
Kronos International, Inc. 9.50% Senior Secured Notes due 2029	$	-	$	292.3
Kronos International, Inc. 3.75% Senior Secured Notes due 2025		440.9		80.9
Subordinated, Unsecured Term Loan from Contran		-		53.7
Total long-term debt	$	440.9	$	426.9

9.50% Senior Secured Notes due 2029 - On February 12, 2024, for certain eligible holders of existing 3.75% Senior Secured Notes due 2025 (the “Old Notes”) of our wholly-owned subsidiary, Kronos International, Inc. (KII), KII executed an exchange of €325 million principal amount of the outstanding Old Notes for newly issued €276.174 million aggregate outstanding KII 9.50% Senior Secured Notes due March 2029 (the “New Notes” and together with the Old Notes, the “Senior Secured Notes”) plus additional cash consideration of €48.75 million ($52.6 million). Holders of the Old Notes received for each €1,000 principal amount of Old Notes exchanged, €850 in principal amount of New Notes, plus a cash payment in an amount equal to €150. Following the exchange, Old Notes totaling €75 million principal amount that were not exchanged continue to remain outstanding. In connection with the exchange, the indenture governing the Old Notes was amended to conform to the restrictive covenants in the indenture governing the New Notes

and to make other conforming changes. KII did not receive any cash proceeds from the issuance and delivery of the New Notes in connection with the exchange. We also entered into a new $53.7 million unsecured term loan from Contran Corporation (described below) in connection with the exchange.

The New Notes:

● bear interest at 9.50% per annum, payable semi-annually on March 15 and September 15 of each year, payments begin on September 15, 2024;

● have a maturity date of March 15, 2029. Prior to March 15, 2026, we may redeem some or all of the New Notes at a price equal to 100% of the principal amount thereof, plus an applicable premium as of the date of the redemption as described in the indenture governing our New Notes plus accrued and unpaid interest. On or after March 15, 2026, we may redeem the New Notes at redemption prices ranging from 104.750% of the principal amount, declining to 100% on or after March 15, 2028, plus accrued and unpaid interest. In addition, on or before March 15, 2026, we may redeem up to 40% of the New Notes with the net proceeds of certain public or private equity offerings at 109.50% of the principal amount, plus accrued and unpaid interest, provided that following the redemption at least 50% of the New Notes remain outstanding. If we or our subsidiaries experience certain change of control events, as outlined in the indenture governing our New Notes, we would be required to make an offer to purchase the New Notes at 101% of the principal amount thereof, plus accrued and unpaid interest. We would also be required to make an offer to purchase a specified portion of the New Notes at par value, plus accrued and unpaid interest, in the event that we and our subsidiaries generate a certain amount of net proceeds from the sale of assets outside the ordinary course of business, and such net proceeds are not otherwise used for specified purposes within a specified time period as described in the indenture governing our New Notes;

● are fully and unconditionally guaranteed, jointly and severally, on a senior secured basis by Kronos Worldwide, Inc. and each of our direct and indirect domestic, wholly-owned subsidiaries;

● are collateralized by a first priority lien on (i) 100% of the common stock or other ownership interests of each existing and future direct domestic subsidiary of KII and the guarantors, and (ii) 65% of the voting common stock or other ownership interests and 100% of the non-voting common stock or other ownership interests of each non-U.S. subsidiary that is directly owned by KII or any guarantor;

● contain a number of covenants and restrictions which, among other things, restrict our ability to incur or guarantee additional debt, incur liens, pay dividends or make other restricted payments, or merge or consolidate with, or sell or transfer substantially all of our assets to, another entity, and contain other provisions and restrictive covenants customary in lending transactions of this type (however, there are no ongoing financial maintenance covenants); and

● contain customary default provisions, including a default under any of our other indebtedness in excess of $50.0 million.

At March 31, 2024 the carrying value of the New Notes (€276.174 million aggregate principal amount outstanding) is stated net of unamortized debt issuance costs of $5.6 million. As a result of the note exchange, in the first quarter of 2024 we recognized a non-cash pre-tax interest charge of $1.5 million included in interest expense related to the write-off of the deferred financing costs associated with the Old Notes and capitalized $5.7 million in debt issuance costs associated with the New Notes.    

Subordinated, Unsecured Term Loan from Contran - As part of the refinancing of a majority of our Old Notes discussed above, we borrowed $53.7 million (€50.0 million) from Contran through the issuance of an unsecured, subordinated term promissory note dated February 12, 2024 (the “Contran Term Loan”). The Contran Term Loan is guaranteed by our domestic wholly-owned subsidiaries. Our obligations under the Contran Term Loan, and the obligations of the guarantors under the related guaranties, are unsecured and subordinated in right of payment to our Senior Secured Notes and our $225 million global revolving credit facility (Global Revolver). Interest on the Contran Term Loan is payable in cash at an interest rate of 11.5%. The additional interest rate spread of 2% over the interest rate on the New Notes was based upon comparable debt transactions at the time of issuance. The Contran Term Loan matures on demand (but no earlier than September 2029), is not subject to any amortization payments and is prepayable at par beginning in March 2026. The restrictive covenants in the Contran Term Loan are substantially similar to those contained in the indenture governing our New Notes. In accordance with our related party transaction policy, the audit committee of our board of directors, comprised of the independent directors, approved the terms and conditions of the term loan from Contran.

3.75% Senior Secured Notes due 2025 - At March 31, 2024, the carrying value of our remaining Old Notes (€75 million aggregate principal amount outstanding) is $80.9 million. In connection with the issuance of the New Notes in February 2024, the indenture governing the Old Notes was amended to conform to the restrictive covenants in the indenture governing the New Notes and to make other conforming changes.

Revolving credit facility - During the first three months of 2024, we had no borrowings or repayments under our $225 million global revolving credit facility and at March 31, 2024, the full $225 million was available for borrowing.

Other - We are in compliance with all of our debt covenants at March 31, 2024.

XML

Accounts payable and accrued liabilities

3 Months Ended

Mar. 31, 2024

Accounts payable and accrued liabilities

Accounts payable and accrued liabilities

Note 6 - Accounts payable and accrued liabilities:

	December 31,		March 31,
	2023		2024
	(In millions)
Accounts payable	$	218.7	$	143.9
Accrued sales discounts and rebates		22.5		10.5
Employee benefits		24.7		23.4
Payables to affiliates:
LPC		19.9		21.0
Income taxes payable to Valhi		10.8		11.6
Other		.6		.6
Operating lease liabilities		3.9		3.6
Other		54.3		36.7
Total	$	355.4	$	251.3

XML

Other noncurrent liabilities

3 Months Ended

Mar. 31, 2024

Other noncurrent liabilities

Other noncurrent liabilities

Note 7 - Other noncurrent liabilities:

	December 31,		March 31,
	2023		2024
	(In millions)
Accrued postretirement benefits	$	6.4	$	6.2
Employee benefits		4.9		4.7
Other		10.5		10.5
Total	$	21.8	$	21.4

XML

Revenue Recognition

3 Months Ended

Mar. 31, 2024

Revenue From Contract With Customer [Abstract]

Revenue Recognition

Note 8 - Revenue recognition:

The following table disaggregates our net sales by place of manufacture (point of origin) and to the location of the customer (point of destination), which are the categories that depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors.

	Three months ended
	March 31,
	2023		2024
	(In millions)
Net sales - point of origin:
United States	$	255.8	$	240.9
Germany		186.0		212.2
Canada		90.9		89.3
Norway		71.9		71.0
Belgium		68.8		69.6
Eliminations		(247.1)		(204.2)
Total	$	426.3	$	478.8
Net sales - point of destination:
Europe	$	201.1	$	214.9
North America		148.6		166.0
Other		76.6		97.9
Total	$	426.3	$	478.8

XML

Employee benefit plans

3 Months Ended

Mar. 31, 2024

Employee benefit plans

Employee benefit plans

Note 9 - Employee benefit plans:

The components of net periodic defined benefit pension cost are presented in the table below.

	Three months ended
	March 31,
	2023		2024
	(In millions)
Net periodic pension cost (income):
Service cost	$	1.6	$	1.7
Interest cost		5.1		5.0
Expected return on plan assets		(4.8)		(5.3)
Recognized actuarial losses		.6		.6
Total	$	2.5	$	2.0

We expect our 2024 contributions for our pension plans to be approximately $17 million.

XML

Income taxes

3 Months Ended

Mar. 31, 2024

Income taxes

Income taxes

Note 10 - Income taxes:

	Three months ended
	March 31,
	2023		2024
	(In millions)
Expected tax expense (benefit), at U.S. federal statutory     income tax rate of 21%	$	(4.6)	$	2.4
Non-U.S. tax rates		(.2)		-
Incremental net tax benefit on earnings and losses of U.S.    and non-U.S. companies		-		(.6)
Valuation allowance, net		.2		1.0
Global intangible low-tax income, net		(.5)		.3
Adjustment to the reserve for uncertain tax positions, net		(1.2)		.1
Adjustment of prior year taxes, net		(.4)		-
Nondeductible expenses		-		.2
Other, net		(.2)		.1
Income tax expense (benefit)	$	(6.9)	$	3.5
Comprehensive provision (benefit) for income taxes allocable to:
Net income (loss)	$	(6.9)	$	3.5
Other comprehensive income - pension plans		.1		.2
Total	$	(6.8)	$	3.7

The amount shown in the preceding table of our income tax rate reconciliation for non-U.S. tax rates represents the result determined by multiplying the pre-tax earnings or losses of each of our non-U.S. subsidiaries by the difference between the applicable statutory income tax rate for each non-U.S. jurisdiction and the U.S. federal statutory tax rate. The amount shown on such table for incremental net tax benefit on earnings and losses of U.S. and non-U.S. companies includes, as applicable, (i) deferred income taxes (or deferred income tax benefits) associated with the current-year earnings (losses) of all of our non-U.S. subsidiaries and (ii) current U.S. income taxes (or current income tax benefit), including U.S. personal holding company tax, as applicable, attributable to current-year income (losses) of one of our non-U.S. subsidiaries, which subsidiary is treated as a dual resident for U.S. income tax purposes, to the extent the current-year income (losses) of such subsidiary is subject to U.S. income tax under the U.S. dual-resident provisions of the Internal Revenue Code.

During the first quarter of 2023, we recognized a non-cash deferred income tax benefit of $1.0 million relating to a decrease in our unrecognized tax benefits due to the expiration of certain statutes of limitations.

Tax authorities are examining certain of our U.S. and non-U.S. tax returns and may propose tax deficiencies, including penalties and interest. We believe we have adequate accruals for additional taxes and related interest expense which could ultimately result from tax examinations. We believe the ultimate disposition of tax examinations should not have a material adverse effect on our consolidated financial position, results of operations or liquidity. We currently estimate that our unrecognized tax benefits will not change materially during the next twelve months.

XML

Stockholders' equity

3 Months Ended

Mar. 31, 2024

Stockholders' equity

Stockholders' equity

Note 11 - Stockholders’ equity:

Changes in accumulated other comprehensive loss are presented in the table below. See Note 9 for discussion of our defined benefit pension plans.

	Three months ended
	March 31,
	2023		2024
	(In millions)
Accumulated other comprehensive loss, net of tax:
Currency translation:
Balance at beginning of period	$	(269.2)	$	(265.5)
Other comprehensive loss		(7.0)		(20.6)
Balance at end of period	$	(276.2)	$	(286.1)
Defined benefit pension plans:
Balance at beginning of period	$	(63.1)	$	(76.0)
Other comprehensive income - amortization    of prior service cost and net losses included in    net periodic pension cost		.5		.5
Balance at end of period	$	(62.6)	$	(75.5)
OPEB plans:
Balance at beginning of period	$	.8	$	.4
Other comprehensive loss - amortization    of prior service credit and net losses    included in net periodic OPEB cost		(.1)		-
Balance at end of period	$	.7	$	.4
Total accumulated other comprehensive loss:
Balance at beginning of period	$	(331.5)	$	(341.1)
Other comprehensive loss		(6.6)		(20.1)
Balance at end of period	$	(338.1)	$	(361.2)

Our board of directors has previously authorized the repurchase of up to 2.0 million shares of our common stock in open market transactions, including block purchases, or in privately-negotiated transactions at unspecified prices and over an unspecified period of time. We may repurchase our common stock from time to time as market conditions permit. The stock repurchase program does not include specific price targets or timetables and may be suspended at any time. Depending on market conditions, we may terminate the program prior to its completion. We use cash on hand or other sources of liquidity to acquire the shares. Repurchased shares are added to our treasury and subsequently cancelled upon approval of the board of directors.

In February 2023, we cancelled 133,897 shares of treasury stock purchased in the fourth quarter of 2022. During the first quarter of 2023, we acquired 159,796 shares of our common stock in market transactions for an aggregate purchase price of $1.4 million, which shares were accounted for as treasury stock at March 31, 2023 and were subsequently cancelled. At March 31, 2024, 1,017,518 shares are available for repurchase under this stock repurchase program.

XML

Commitments and contingencies

3 Months Ended

Mar. 31, 2024

Commitments and contingencies

Commitments and contingencies

Note 12 - Commitments and contingencies:

We are involved in various environmental, contractual, product liability, patent (or intellectual property), employment and other claims and disputes incidental to our business. At least quarterly our management discusses and evaluates the status of any pending litigation to which we are a party. The factors considered in such evaluation include, among other things, the nature of such pending cases, the status of such pending cases, the advice of legal counsel and our experience in similar cases (if any). Based on such evaluation, we make a determination as to whether we believe (i) it is probable a loss has been incurred, and if so if the amount of such loss (or a range of loss) is reasonably estimable, or (ii) it is reasonably possible but not probable a loss has been incurred, and if so if the amount of such loss (or a range of loss) is reasonably estimable, or (iii) the probability a loss has been incurred is remote. We have not accrued any amounts for litigation matters because it is not reasonably possible we have incurred a loss that would be material to our consolidated financial statements, results of operations or liquidity.

XML

Financial instruments

3 Months Ended

Mar. 31, 2024

Financial instruments

Financial instruments

Note 13 - Financial instruments:

See Note 4 for information on how we determine fair value of our marketable securities.

The following table presents the financial instruments that are not carried at fair value but which require fair value disclosure:

	December 31, 2023				March 31, 2024
	Carrying		Fair		Carrying		Fair
	amount		value		amount		value
	(In millions)
Cash, cash equivalents and restricted cash	$	202.1	$	202.1	$	127.3	$	127.3
Long-term debt:
Fixed rate 9.50% Senior Secured Notes due 2029		-		-		292.3		318.5
Fixed rate 3.75% Senior Secured Notes due 2025		440.9		424.5		80.9		79.9

At March 31, 2024, the estimated market price of our 9.50% Senior Secured Notes due 2029 was €1,069 per €1,000 principal amount, and the estimated market price of our 3.75% Senior Secured Notes due 2025 was €987 per €1,000 principal amount. The fair values of our Senior Secured Notes were based on quoted market prices; however, these quoted market prices represented Level 2 inputs because the markets in which the Senior Secured Notes trade were not active. Due to their near-term maturities, the carrying amounts of accounts receivable and accounts payable are considered equivalent to fair value. See Notes 2 and 6.

XML

Other operating income (expense), net

3 Months Ended

Mar. 31, 2024

Other operating income (expense), net

Other operating income (expense), net

Note 14 - Other operating income (expense), net:

On August 24, 2020, LPC temporarily halted production due to Hurricane Laura. Although storm damage to core processing facilities was not extensive, a variety of factors, including loss of utilities and limited access and availability of employees and raw materials, prevented the resumption of operations until September 25, 2020. The majority of our losses from property damage and our share of LPC’s lost production and other costs resulting from the disruption of operations, were covered by insurance. We recognized an aggregate gain of $1.7 million in the first quarter of 2023, which is included in other operating expense, net on our Condensed Consolidated Statement of Operations.

XML

Recent accounting pronouncements

3 Months Ended

Mar. 31, 2024

Recent accounting pronouncements

Recent accounting pronouncements

Note 15 - Recent accounting pronouncements:

In November 2023, the Financial Accounting Standards Board (FASB) issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The ASU requires public companies to disclose significant segment expenses and other segment items on an annual and interim basis. The ASU also mandates public companies to provide all annual segment disclosures currently required annually in interim periods. Public entities with a single reportable segment are required to provide the new disclosures and all disclosures required under ASC 280. Public companies will also be required to disclose the title and position of the chief operating decision maker (CODM) and explain how the CODM uses the reported measure of segment profit or loss in assessing segment performance and allocation of resources. The ASU is effective for us beginning with our 2024 Annual Report, and for interim reporting, in the first quarter of 2025, with retrospective application required. We are in the process of evaluating the additional disclosure requirements across all segments.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The ASU requires additional annual disclosure and disaggregation for the rate reconciliation, income taxes paid and income tax expense by federal, state and foreign tax jurisdictions. In addition, the standard increases the disclosure requirements for items included in the rate reconciliation that meet a quantitative threshold. The ASU is effective for us beginning with our 2025 Annual Report. The ASU may be applied prospectively; however, entities have the option to apply it retrospectively. We are in the process of evaluating the additional disclosure requirements.

XML

Restructuring costs

3 Months Ended

Mar. 31, 2024

Restructuring costs

Restructuring costs

Note 16 – Restructuring costs:

In response to the extended period of reduced demand in 2023, we took measures to reduce our operating costs and improve our long-term cost structure such as the implementation of certain voluntary and involuntary workforce reductions during the third quarter of 2023 that primarily impacted our European operations. A substantial portion of our workforce reductions were accomplished through voluntary programs, for which eligible workforce reduction costs are recognized at the time both the employee and employer are irrevocably committed to the terms of the separation. These workforce reductions impacted approximately 100 employees. We recognized a total of approximately $6 million in charges primarily in the fourth quarter of 2023 related to workforce reductions we implemented during the second half of the year with the majority of related cash payments expected to be paid in the first half of 2024.

In April 2024, we announced plans to close our sulfate process line at our plant in Varennes, Canada by the third quarter of 2024. As a result of the sulfate process line closure, we expect to recognize a charge of approximately $2 million primarily to cost of sales in the second quarter of 2024 related to workforce reductions for employees impacted. In addition, approximately $15 million in non-cash charges related to the closure of the line are expected to be reflected in cost of sales in the second and third quarters of 2024.

A summary of the activity in our accrued restructuring costs for the first quarter of 2024 is shown in the table below (in millions):

	Amount
	(In millions)
Accrued workforce reduction costs at December 31, 2023	$	5.0
Workforce reduction costs accrued		(.1)
Workforce reduction costs paid		(1.6)
Currency translation adjustments, net		(.1)
Accrued workforce reduction costs at March 31, 2024	$	3.2
Amounts recognized in the balance sheet:
Current liability	$	3.2
Noncurrent liability		-
Total	$	3.2

XML

Summary of significant accounting policies (Policies)

3 Months Ended

Mar. 31, 2024

Organization and basis of presentation

Organization

Organization - At March 31, 2024, Valhi, Inc. (NYSE: VHI) held approximately 50% of our outstanding common stock and a wholly-owned subsidiary of NL Industries, Inc. (NYSE: NL) held approximately 31% of our common stock. Valhi owned approximately 83% of NL’s outstanding common stock and a wholly-owned subsidiary of Contran Corporation held approximately 91% of Valhi’s outstanding common stock. A majority of Contran’s outstanding voting stock is held directly by Lisa K. Simmons, Thomas C. Connelly (the husband of Ms. Simmons’ late sister), and various family trusts established for the benefit of Ms. Simmons, Mr. Connelly and their children and for which Ms. Simmons, Mr. Connelly, or Mr. Connelly’s sister, as applicable, serve as trustee (collectively, the “Other Trusts”). With respect to the Other Trusts for which Mr. Connelly or his sister serves as trustee, the trustee is required to vote the shares of Contran voting stock held in such trusts in the same manner as Ms. Simmons. Such voting rights of Ms. Simmons last through April 22, 2030 and are personal to Ms. Simmons. The remainder of Contran’s outstanding voting stock is held by another trust (the “Family Trust”), which was established for the benefit of Ms. Simmons and her late sister and their children and for which a third-party financial institution serves as trustee. Consequently, at March 31, 2024, Ms. Simmons and the Family Trust may be deemed to control Contran, and therefore may be deemed to indirectly control the wholly-owned subsidiary of Contran, Valhi, NL and us.

Basis of Presentation

Basis of presentation - The unaudited Condensed Consolidated Financial Statements contained in this Quarterly Report have been prepared on the same basis as the audited Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2023 that we filed with the Securities and Exchange Commission (SEC) on March 6, 2024 (2023 Annual Report). In our opinion, we have made all necessary adjustments (which include only normal recurring adjustments), in order to state fairly, in all material respects, our consolidated financial position, results of operations and cash flows as of the dates and for the periods presented. We have condensed the Consolidated Balance Sheet at December 31, 2023 contained in this Quarterly Report as compared to our audited Consolidated Financial Statements at that date, and we have omitted certain information and footnote disclosures (including those related to the Consolidated Balance Sheet at December 31, 2023) normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (GAAP). Our results of operations for the interim period ended March 31, 2024 may not be indicative of our operating results for the full year. The Condensed Consolidated Financial Statements contained in this Quarterly Report should be read in conjunction with our 2023 Consolidated Financial Statements contained in our 2023 Annual Report.

Unless otherwise indicated, references in this report to “we,” “us” or “our” refer to Kronos Worldwide, Inc. and its subsidiaries (NYSE: KRO) taken as a whole.

Commitments and Contingencies

We are involved in various environmental, contractual, product liability, patent (or intellectual property), employment and other claims and disputes incidental to our business. At least quarterly our management discusses and evaluates the status of any pending litigation to which we are a party. The factors considered in such evaluation include, among other things, the nature of such pending cases, the status of such pending cases, the advice of legal counsel and our experience in similar cases (if any). Based on such evaluation, we make a determination as to whether we believe (i) it is probable a loss has been incurred, and if so if the amount of such loss (or a range of loss) is reasonably estimable, or (ii) it is reasonably possible but not probable a loss has been incurred, and if so if the amount of such loss (or a range of loss) is reasonably estimable, or (iii) the probability a loss has been incurred is remote. We have not accrued any amounts for litigation matters because it is not reasonably possible we have incurred a loss that would be material to our consolidated financial statements, results of operations or liquidity.

XML

Accounts and other receivables, net (Tables)

3 Months Ended

Mar. 31, 2024

Accounts and other receivables, net

Accounts and other receivables, net

	December 31,		March 31,
	2023		2024
	(In millions)
Trade receivables	$	273.6	$	330.8
Recoverable VAT and other receivables		23.8		19.5
Receivables from affiliates, other:
Louisiana Pigment Company (LPC)		16.9		-
Other		.4		.4
Refundable income taxes		1.9		2.0
Allowance for doubtful accounts		(4.1)		(4.0)
Total	$	312.5	$	348.7

XML

Inventories, net (Tables)

3 Months Ended

Mar. 31, 2024

Inventories, net

Schedule of Inventories, Net

	December 31,		March 31,
	2023		2024
	(In millions)
Raw materials	$	188.3	$	148.3
Work in process		30.8		25.6
Finished products		249.6		208.8
Supplies		95.9		93.1
Total	$	564.6	$	475.8

XML

Marketable securities (Tables)

3 Months Ended

Mar. 31, 2024

Marketable securities

Classification of Marketable securities

	Fair value
	measurement	Market		Cost		Unrealized
Marketable security	level	value		basis		loss
		(In millions)
December 31, 2023:
Valhi common stock	1	$	2.2	$	3.2	$	(1.0)
March 31, 2024:
Valhi common stock	1	$	2.5	$	3.2	$	(.7)

XML

Long-term debt (Tables)

3 Months Ended

Mar. 31, 2024

Long-term debt

Components of Long Term Debt

	December 31,		March 31,
	2023		2024
	(In millions)
Kronos International, Inc. 9.50% Senior Secured Notes due 2029	$	-	$	292.3
Kronos International, Inc. 3.75% Senior Secured Notes due 2025		440.9		80.9
Subordinated, Unsecured Term Loan from Contran		-		53.7
Total long-term debt	$	440.9	$	426.9

XML

Accounts payable and accrued liabilities (Tables)

3 Months Ended

Mar. 31, 2024

Accounts payable and accrued liabilities

Components of Accounts Payable and Accrued Liabilities

	December 31,		March 31,
	2023		2024
	(In millions)
Accounts payable	$	218.7	$	143.9
Accrued sales discounts and rebates		22.5		10.5
Employee benefits		24.7		23.4
Payables to affiliates:
LPC		19.9		21.0
Income taxes payable to Valhi		10.8		11.6
Other		.6		.6
Operating lease liabilities		3.9		3.6
Other		54.3		36.7
Total	$	355.4	$	251.3

XML

Other noncurrent liabilities (Tables)

3 Months Ended

Mar. 31, 2024

Other noncurrent liabilities

Components of Other noncurrent liabilities

	December 31,		March 31,
	2023		2024
	(In millions)
Accrued postretirement benefits	$	6.4	$	6.2
Employee benefits		4.9		4.7
Other		10.5		10.5
Total	$	21.8	$	21.4

XML

Revenue Recognition (Tables)

3 Months Ended

Mar. 31, 2024

Revenue From Contract With Customer [Abstract]

Disaggregation of Net Sales by Place of Manufacture and to Location of Customer

	Three months ended
	March 31,
	2023		2024
	(In millions)
Net sales - point of origin:
United States	$	255.8	$	240.9
Germany		186.0		212.2
Canada		90.9		89.3
Norway		71.9		71.0
Belgium		68.8		69.6
Eliminations		(247.1)		(204.2)
Total	$	426.3	$	478.8
Net sales - point of destination:
Europe	$	201.1	$	214.9
North America		148.6		166.0
Other		76.6		97.9
Total	$	426.3	$	478.8

XML

Employee benefit plans (Tables)

3 Months Ended

Mar. 31, 2024

Employee benefit plans

Components of Net Periodic Benefit Cost

	Three months ended
	March 31,
	2023		2024
	(In millions)
Net periodic pension cost (income):
Service cost	$	1.6	$	1.7
Interest cost		5.1		5.0
Expected return on plan assets		(4.8)		(5.3)
Recognized actuarial losses		.6		.6
Total	$	2.5	$	2.0

XML

Income taxes (Tables)

3 Months Ended

Mar. 31, 2024

Income taxes

Schedule of effective income tax rate reconciliation

	Three months ended
	March 31,
	2023		2024
	(In millions)
Expected tax expense (benefit), at U.S. federal statutory     income tax rate of 21%	$	(4.6)	$	2.4
Non-U.S. tax rates		(.2)		-
Incremental net tax benefit on earnings and losses of U.S.    and non-U.S. companies		-		(.6)
Valuation allowance, net		.2		1.0
Global intangible low-tax income, net		(.5)		.3
Adjustment to the reserve for uncertain tax positions, net		(1.2)		.1
Adjustment of prior year taxes, net		(.4)		-
Nondeductible expenses		-		.2
Other, net		(.2)		.1
Income tax expense (benefit)	$	(6.9)	$	3.5
Comprehensive provision (benefit) for income taxes allocable to:
Net income (loss)	$	(6.9)	$	3.5
Other comprehensive income - pension plans		.1		.2
Total	$	(6.8)	$	3.7

XML

Stockholders' equity (Tables)

3 Months Ended

Mar. 31, 2024

Stockholders' equity

Schedule of changes in accumulated other comprehensive loss

	Three months ended
	March 31,
	2023		2024
	(In millions)
Accumulated other comprehensive loss, net of tax:
Currency translation:
Balance at beginning of period	$	(269.2)	$	(265.5)
Other comprehensive loss		(7.0)		(20.6)
Balance at end of period	$	(276.2)	$	(286.1)
Defined benefit pension plans:
Balance at beginning of period	$	(63.1)	$	(76.0)
Other comprehensive income - amortization    of prior service cost and net losses included in    net periodic pension cost		.5		.5
Balance at end of period	$	(62.6)	$	(75.5)
OPEB plans:
Balance at beginning of period	$	.8	$	.4
Other comprehensive loss - amortization    of prior service credit and net losses    included in net periodic OPEB cost		(.1)		-
Balance at end of period	$	.7	$	.4
Total accumulated other comprehensive loss:
Balance at beginning of period	$	(331.5)	$	(341.1)
Other comprehensive loss		(6.6)		(20.1)
Balance at end of period	$	(338.1)	$	(361.2)

XML

Financial instruments (Tables)

3 Months Ended

Mar. 31, 2024

Financial instruments

Financial Instruments not Carried at Fair Value but which Require Fair Value Disclosure

	December 31, 2023				March 31, 2024
	Carrying		Fair		Carrying		Fair
	amount		value		amount		value
	(In millions)
Cash, cash equivalents and restricted cash	$	202.1	$	202.1	$	127.3	$	127.3
Long-term debt:
Fixed rate 9.50% Senior Secured Notes due 2029		-		-		292.3		318.5
Fixed rate 3.75% Senior Secured Notes due 2025		440.9		424.5		80.9		79.9

XML

Restructuring costs (Tables)

3 Months Ended

Mar. 31, 2024

Restructuring costs

Schedule of accrued workforce reduction costs

	Amount
	(In millions)
Accrued workforce reduction costs at December 31, 2023	$	5.0
Workforce reduction costs accrued		(.1)
Workforce reduction costs paid		(1.6)
Currency translation adjustments, net		(.1)
Accrued workforce reduction costs at March 31, 2024	$	3.2
Amounts recognized in the balance sheet:
Current liability	$	3.2
Noncurrent liability		-
Total	$	3.2

XML

Organization and basis of presentation - Additional Information (Detail)	3 Months Ended
	Mar. 31, 2024
Valhi Inc | Parent Company
Organization And Basis Of Presentation [Line Items]
Parent company ownership interest	50.00%
Valhi Inc | NL Industries Inc.
Organization And Basis Of Presentation [Line Items]
Ownership percentage in company	83.00%
NL Industries Inc. | Parent Company
Organization And Basis Of Presentation [Line Items]
Parent company ownership interest	31.00%
Contran
Organization And Basis Of Presentation [Line Items]
Controlling interest description	Consequently, at March 31, 2024, Ms. Simmons and the Family Trust may be deemed to control Contran, and therefore may be deemed to indirectly control the wholly-owned subsidiary of Contran, Valhi, NL and us.
Contran | Valhi Inc
Organization And Basis Of Presentation [Line Items]
Ownership percentage of parent company held by related party	91.00%

XML

Accounts and other receivables, net - Accounts and Other Receivables, Net (Detail) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Accounts Notes And Loans Receivable [Line Items]
Allowance for doubtful accounts	$ (4.0)	$ (4.1)
Total	348.7	312.5
Trade receivables
Accounts Notes And Loans Receivable [Line Items]
Accounts and other receivables	330.8	273.6
Recoverable VAT and other receivables
Accounts Notes And Loans Receivable [Line Items]
Accounts and other receivables	19.5	23.8
Refundable income taxes
Accounts Notes And Loans Receivable [Line Items]
Refundable income taxes	2.0	1.9
Louisiana Pigment Company (LPC) | Trade Items
Accounts Notes And Loans Receivable [Line Items]
Receivables from affiliates		16.9
Other Affiliates | Other Receivable
Accounts Notes And Loans Receivable [Line Items]
Receivables from affiliates	$ 0.4	$ 0.4

XML

Inventories, net - Schedule of Inventories, Net (Detail) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Inventories, net
Raw materials	$ 148.3	$ 188.3
Work in process	25.6	30.8
Finished products	208.8	249.6
Supplies	93.1	95.9
Total	$ 475.8	$ 564.6

XML

Marketable Securities - Classification of marketable securities (Detail) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Marketable securities
Market value	$ 2.5	$ 2.2
Level 1 | Common stock | Valhi
Marketable securities
Market value	2.5	2.2
Cost basis	3.2	3.2
Unrealized loss	$ (0.7)	$ (1.0)

XML

Marketable Securities - Additional Information (Detail) - Valhi Inc - Common stock - $ / shares	Mar. 31, 2024	Dec. 31, 2023
Marketable securities
Investments in publicly-traded shares (in shares)	144,000	144,000
Quoted market price of per share (in dollars per share)	$ 17.18	$ 15.19

XML

Long-term debt - Components of Long-Term Debt (Detail) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Long-term debt
Total long-term debt	$ 426.9	$ 440.9
9.50% Senior Secured Notes due 2029
Long-term debt
Kronos International, Inc.	292.3
3.75% Senior Secured Notes due 2025
Long-term debt
Kronos International, Inc.	80.9	440.9
Subordinated, Unsecured Term Loan from Contran
Long-term debt
Subordinated debt	53.7
Kronos International, Inc | 9.50% Senior Secured Notes due 2029
Long-term debt
Kronos International, Inc.	292.3
Kronos International, Inc | 3.75% Senior Secured Notes due 2025
Long-term debt
Kronos International, Inc.	$ 80.9	$ 440.9

XML

Long-term debt - Senior Notes - Additional Information (Detail) $ in Millions			3 Months Ended
	Feb. 12, 2024 USD ($)	Feb. 12, 2024 EUR (€)	Mar. 31, 2024 USD ($)	Mar. 31, 2024 EUR (€)	Feb. 12, 2024 EUR (€)	Dec. 31, 2023 USD ($)
Senior Notes
Long-term debt
Minimum amount of debt default for using customary default provisions | $	$ 50.0
On or Before March 15, 2026
Long-term debt
Private equity offerings	109.50%	109.50%
3.75% Senior Secured Notes due 2025
Long-term debt
Debt instrument principal amount					€ 325,000,000
Debt instrument base principal amount				€ 1,000
Debt instrument interest rate	3.75%		3.75%	3.75%	3.75%
Interest expense | $			$ 1.5
Cash consideration to be paid for Old Note holders	$ 52.6	€ 48,750,000
Principal amount of old note exchange for new note					€ 1,000
Cash consideration paid for each of €1,000 principal amount of Old Note		€ 150
Principal amount outstanding | $			$ 80.9			$ 440.9
9.50% Senior Secured Notes due 2029
Long-term debt
Debt instrument principal amount				€ 276,174,000	€ 276,174,000
Debt instrument base principal amount				€ 1,000
Debt instrument interest rate	9.50%		9.50%	9.50%	9.50%
Debt instrument, redemption price percentage	100.00%	100.00%
Debt instrument redemption price percent if experience certain specified change of control events	101.00%	101.00%
Unamortized debt issuance costs | $			$ 5.6
Debt issuance costs | $			5.7
Principal amount of New Note executed for each €1,000 principal of old note					€ 850
Remaining outstanding					75,000,000
Principal amount outstanding | $			$ 292.3
9.50% Senior Secured Notes due 2029 | On or After March 15, 2026
Long-term debt
Debt instrument, redemption price percentage	104.75%	104.75%
9.50% Senior Secured Notes due 2029 | On or After March 15, 2028
Long-term debt
Debt instrument, redemption price percentage	100.00%	100.00%
9.50% Senior Secured Notes due 2029 | On or Before March 15, 2026
Long-term debt
Debt instrument, percentage of debt that may be redeemed	40.00%	40.00%
Redemption percentage	50.00%	50.00%
Subordinated, unsecured term loan
Long-term debt
Debt instrument principal amount	$ 53.7				€ 50,000,000.0
Debt instrument interest rate	11.50%				11.50%
Kronos International, Inc | 3.75% Senior Secured Notes due 2025
Long-term debt
Debt instrument principal amount				€ 75,000,000
Debt instrument interest rate			3.75%	3.75%
Principal amount outstanding | $			$ 80.9			$ 440.9
Kronos International, Inc | 9.50% Senior Secured Notes due 2029
Long-term debt
Debt instrument interest rate			9.50%	9.50%
Debt instrument, interest payment terms			bear interest at 9.50% per annum, payable semi-annually on March 15 and September 15 of each year, payments begin on September 15, 2024;
Debt instrument, frequency of periodic payment of interest			semi-annually
Debt instrument, date of first semi-annual interest payment	--03-15	--03-15
Debt instrument, date of second semi-annual interest payment	--09-15	--09-15
Debt Instrument, date of first required semi-annual payment	Sep. 15, 2024	Sep. 15, 2024
Principal amount outstanding | $			$ 292.3
Kronos International, Inc | 9.50% Senior Secured Notes due 2029 | Collateral Pledged | Direct Domestic Subsidiary of KII and Guarantors
Long-term debt
Ownership interest percentage owned by parent	100.00%				100.00%
Kronos International, Inc | 9.50% Senior Secured Notes due 2029 | Collateral Pledged | Non US Subsidiary Directly Owned by KII or any Guarantor
Long-term debt
Ownership interest percentage owned by parent	65.00%				65.00%
Kronos International, Inc | 9.50% Senior Secured Notes due 2029 | Collateral Pledged | Non US Subsidiary Directly Owned by KII or any Guarantor | Non-voting Common Stock
Long-term debt
Ownership interest percentage owned by parent	100.00%				100.00%

XML

Long-term debt - Subordinated, Unsecured Term Loan from Contran and Revolving Credit Facilities - Additional Information (Detail) € in Millions, $ in Millions		3 Months Ended
	Feb. 12, 2024 USD ($)	Mar. 31, 2024 USD ($)	Feb. 12, 2024 EUR (€)
Subordinated, unsecured term loan
Long-term debt
Debt instrument principal amount	$ 53.7		€ 50.0
Debt instrument interest rate	11.50%		11.50%
Debt instrument basis spread on variable rate	2.00%
Global Revolver
Long-term debt
Maximum borrowing capacity	$ 225.0	$ 225.0
Borrowings under credit facility during the period		0.0
Repayments of lines of credit		0.0
Amount available for Borrowing		$ 225.0

XML

Accounts payable and accrued liabilities - Components of Accounts Payable and Accrued Liabilities (Detail) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Accounts payable and accrued liabilities
Accounts payable	$ 143.9	$ 218.7
Accrued sales discounts and rebates	10.5	22.5
Employee benefits	23.4	24.7
Operating lease liabilities	$ 3.6	$ 3.9
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Total	Total
Other	$ 36.7	$ 54.3
Total	251.3	355.4
Other payable
Accounts payable and accrued liabilities
Current payables to affiliates	0.6	0.6
Louisiana Pigment Company, L.P.
Accounts payable and accrued liabilities
Current payables to affiliates	21.0	19.9
Valhi
Accounts payable and accrued liabilities
Current payables to affiliates	$ 11.6	$ 10.8

XML

Other noncurrent liabilities - Components of Other Noncurrent Liabilities (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Other noncurrent liabilities
Accrued postretirement benefits	$ 6.2	$ 6.4
Employee benefits	4.7	4.9
Other	10.5	10.5
Total	$ 21.4	$ 21.8

XML

Revenue Recognition - Disaggregation of Net Sales by Place of Manufacture and to Location of Customer (Detail) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Entity Wide Information Revenue From External Customer [Line Items]
Net sales	$ 478.8	$ 426.3
Point of origin
Entity Wide Information Revenue From External Customer [Line Items]
Net sales	478.8	426.3
Point of origin | Reportable geographical components | United States
Entity Wide Information Revenue From External Customer [Line Items]
Net sales	240.9	255.8
Point of origin | Reportable geographical components | Germany
Entity Wide Information Revenue From External Customer [Line Items]
Net sales	212.2	186.0
Point of origin | Reportable geographical components | Canada
Entity Wide Information Revenue From External Customer [Line Items]
Net sales	89.3	90.9
Point of origin | Reportable geographical components | Belgium
Entity Wide Information Revenue From External Customer [Line Items]
Net sales	69.6	68.8
Point of origin | Reportable geographical components | Norway
Entity Wide Information Revenue From External Customer [Line Items]
Net sales	71.0	71.9
Point of origin | Eliminations
Entity Wide Information Revenue From External Customer [Line Items]
Net sales	(204.2)	(247.1)
Point of destination
Entity Wide Information Revenue From External Customer [Line Items]
Net sales	478.8	426.3
Point of destination | Europe
Entity Wide Information Revenue From External Customer [Line Items]
Net sales	214.9	201.1
Point of destination | North America
Entity Wide Information Revenue From External Customer [Line Items]
Net sales	166.0	148.6
Point of destination | Other
Entity Wide Information Revenue From External Customer [Line Items]
Net sales	$ 97.9	$ 76.6

XML

Employee benefit plans - Components of Net Periodic Benefit Cost (Detail) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2024
Defined Benefit Plan Disclosure [Line Items]
Expected contributions for pension plans in 2024			$ 17.0
Foreign Pension Plans Defined Benefit | Defined benefit pension plans
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 1.7	$ 1.6
Interest cost	5.0	5.1
Expected return on plan assets	(5.3)	(4.8)
Recognized actuarial losses	0.6	0.6
Total	$ 2.0	$ 2.5

XML

Income taxes - Components of Income Taxes and Comprehensive Provision for Income Taxes Allocation (Details) - USD ($) $ in Millions	3 Months Ended		15 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024
Income taxes
Expected tax expense (benefit), at U.S. federal statutory income tax rate of 21%	$ 2.4	$ (4.6)
U.S. Federal statutory income tax rate			21.00%
Non-U.S. tax rates		(0.2)
Incremental net tax benefit on earnings and losses of U.S. and non-U.S. companies	(0.6)
Valuation allowance, net	1.0	0.2
Global intangible low-tax income, net	0.3	(0.5)
Adjustment to the reserve for uncertain tax positions, net	0.1	(1.2)
Adjustment of prior year taxes, net		(0.4)
Nondeductible expenses	0.2
Other, net	0.1	(0.2)
Income tax expense (benefit)	3.5	(6.9)
Comprehensive provision for income taxes (benefit) allocable to:
Net income (loss)	3.5	(6.9)
Other comprehensive income (loss):
Pension plans	0.2	0.1
Total	$ 3.7	(6.8)
Non-cash deferred income tax expense		$ 1.0

XML

Stockholders' equity - Additional Information (Details) - USD ($) $ in Millions	1 Months Ended	3 Months Ended
	Feb. 28, 2023	Dec. 31, 2023	Mar. 31, 2023	Mar. 31, 2024
Accumulated Other Comprehensive Income Loss [Line Items]
Number of shares authorized for repurchase				2,000,000.0
Treasury stock purchased	133,897
Aggregate purchase price			$ 1.4
Shares available for repurchase under the plan				1,017,518
Common stock
Accumulated Other Comprehensive Income Loss [Line Items]
Stock repurchased and acquired in market transactions		159,796
Treasury Stock, Common
Accumulated Other Comprehensive Income Loss [Line Items]
Aggregate purchase price		$ 1.4	$ 1.4

XML

Stockholders' equity - Schedule of Changes in Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning Balance	$ 808.3	$ 957.2
Ending Balance	774.4	912.1
Currency translation
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning Balance	(265.5)	(269.2)
Other comprehensive income (loss)	(20.6)	(7.0)
Ending Balance	(286.1)	(276.2)
Accumulated Defined benefit pension plans | Defined benefit pension plans
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning Balance	(76.0)	(63.1)
Other comprehensive income (loss)	0.5	0.5
Ending Balance	(75.5)	(62.6)
Accumulated Defined benefit pension plans | OPEB Plans
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning Balance	0.4	0.8
Other comprehensive income (loss)		(0.1)
Ending Balance	0.4	0.7
Total Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning Balance	(341.1)	(331.5)
Other comprehensive income (loss)	(20.1)	(6.6)
Ending Balance	$ (361.2)	$ (338.1)

XML

Financial Instruments - Financial Instruments not Carried at Fair Value but which Require Fair Value Disclosure (Detail) - USD ($) $ in Millions	Mar. 31, 2024	Feb. 12, 2024	Dec. 31, 2023	Mar. 31, 2023	Dec. 31, 2022
Financial Instrument At Fair Value [Line Items]
Cash, cash equivalents and restricted cash, Carrying amount	$ 127.3		$ 202.1	$ 184.2	$ 334.6
Cash, cash equivalents and restricted cash, Fair value	127.3		202.1
9.50% Senior Secured Notes due 2029
Financial Instrument At Fair Value [Line Items]
Principal amount outstanding	292.3
Long-term debt - Fixed rate	$ 318.5
Debt instrument interest rate	9.50%	9.50%
3.75% Senior Secured Notes due 2025
Financial Instrument At Fair Value [Line Items]
Principal amount outstanding	$ 80.9		440.9
Long-term debt - Fixed rate	$ 79.9		$ 424.5
Debt instrument interest rate	3.75%	3.75%

XML

Financial Instruments - Additional Information (Detail) - EUR (€)	Mar. 31, 2024	Feb. 12, 2024
3.75% Senior Secured Notes due 2025
Financial Instrument At Fair Value [Line Items]
Debt instrument interest rate	3.75%	3.75%
Debt instrument estimated market price per 1000 principal amount	€ 987
Debt instrument base principal amount	€ 1,000
9.50% Senior Secured Notes due 2029
Financial Instrument At Fair Value [Line Items]
Debt instrument interest rate	9.50%	9.50%
Debt instrument estimated market price per 1000 principal amount	€ 1,069
Debt instrument base principal amount	€ 1,000

XML

Other operating income (expense), net (Detail) $ in Millions	3 Months Ended
	Mar. 31, 2023 USD ($)
Other operating income (expense), net
Insurance settlement gain	$ 1.7

XML

Restructuring costs (Detail) $ in Millions	3 Months Ended
	Mar. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Apr. 30, 2024 USD ($)	Sep. 30, 2023 individual
Restructuring Cost and Reserve [Line Items]
Number of individuals impacted from workforce reductions | individual				100
Restructuring Charges	$ (0.1)
Selling, General and Administrative Expenses
Restructuring Cost and Reserve [Line Items]
Restructuring Charges		$ 6.0
Sulfate Process Line at Plant in Varennes, Canada | 2nd Quarter of 2024
Restructuring Cost and Reserve [Line Items]
Cost of sales			$ 2.0
Sulfate Process Line at Plant in Varennes, Canada | 2nd and 3rd Quarter of 2024
Restructuring Cost and Reserve [Line Items]
Cost of sales			$ 15.0

XML

Restructuring costs - Accrued workforce reduction cost (Details) $ in Millions	3 Months Ended
	Mar. 31, 2024 USD ($)
Restructuring costs
Accrued workforce reduction costs at December 31, 2023	$ 5.0
Workforce reduction costs accrued	(0.1)
Workforce reduction costs paid	(1.6)
Currency translation adjustments, net	(0.1)
Accrued workforce reduction costs at March 31, 2024	3.2
Amounts recognized in the balance sheet:
Current liability	3.2
Accrued workforce reduction cost	$ 3.2